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 3 
Summary 
A role for Wnt signaling in melanocyte specification from neural crest is conserved across vertebrates, 
but possible ongoing roles in melanocyte differentiation have received little attention. Using a systems 
biology approach to investigate the gene regulatory network underlying stable melanocyte 
differentiation in zebrafish highlighted a requirement for a positive feedback loop involving the 
melanocyte master regulator Mitfa. Here we test the hypothesis that Wnt signaling contributes to that 
positive feedback. We show firstly that Wnt signaling remains active in differentiating melanocytes 
and secondly that enhanced Wnt signaling drives elevated transcription of mitfa. We show that 
chemical activation of the Wnt signaling pathway at early stages of melanocyte development 
enhances melanocyte specification as expected, but importantly that at later (differentiation) stages it 
results in altered melanocyte morphology, although melanisation is not obviously affected. 
Downregulation of Wnt signaling also results in altered melanocyte morphology and organisation. We 
conclude that Wnt signaling plays a role in regulating ongoing aspects of melanocyte differentiation in 
zebrafish.    
Significance 
Gene regulatory networks underlie all aspects of the development of specific cell-types. While fate 
specification mechanisms and key genes associated with differentiation are often well-studied, 
mechanisms leading to maintenance of the differentiated state are less well understood, yet they are 
crucial from a disease perspective. Positive feedback loops are predicted to be crucial to these 
maintenance mechanisms. We predicted that such a feedback loop acting on mitfa would be crucial for 
melanocyte maintenance, and provided evidence supporting this hypothesis. Here we provide 
evidence for the first time that in zebrafish ongoing Wnt signaling is likely to contribute to this 
feedback loop.  
Introduction 
Melanocytes are a key derivative of the neural crest, and the mechanisms of melanocyte development 
are of major interest from developmental and stem cell biology and applied biology perspectives, with 
clear relevance to understanding human pigmentary disease (Yamaguchi and Hearing 2014; White et 
al., 2011; Speeckaert et al., 2014; Aoude et al., 2015; Mort et al., 2015). Melanocyte specification 
from neural crest cells has been relatively well-studied, and has illuminated the underlying 
mechanisms of neurocristopathies like the Waardenburg syndromes (Dutton et al., 2001; Lee et al., 
2000; Southard-Smith et al., 1998; Elworthy et al., 2003). Numerous genes contributing to the 
differentiated melanocyte phenotype have been described, but little is known of how stable 
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 4 
melanocyte differentiation is maintained, although this is likely to be significant in understanding 
melanoma where reversion to a more progenitor-like state helps drive proliferation and invasiveness 
(White et al., 2011; Kaufmann et al., 2016). Stability of differentiation is likely to be an emergent 
property of the state of the gene regulatory network (GRN) in differentiated melanocytes.  
Studies in both mouse and zebrafish have shown that melanocyte specification depends upon the 
expression in neural crest cells of Microphthalmia-related Transcription Factor (Mitf; mitfa in 
zebrafish), which encodes a basic Helix-Loop-Helix transcription factor (Steingrimsson et al., 1994; 
Hodgkinson et al., 1993; Lister et al., 1999; Watanabe et al., 2002; Opdecamp et al., 1997). Mitf/mitfa 
functions as the master regulator of melanocyte development as it controls all aspects of melanocyte 
cell biology including melanocyte survival, proliferation, morphology and melanogenesis itself 
(Steingrimsson et al., 2004; Cheli et al., 2010; Levy et al., 2006; Lister et al., 1999). Transcriptional 
activation of Mitf/mitfa depends upon Sox10, a transcription factor of the Sry-related HMG domain 
type, shown to bind directly to the Mitf/mitfa promoter (Hou et al., 2006; Kelsh 2006; Herbarth et al., 
1998; Southard-Smith et al., 1998; Dutton et al., 2001; Elworthy et al., 2003). In addition, Wnt 
signaling, acting via Lef-1 and β-catenin mediated regulation of Mitf/mitfa transcription, is also 
required for melanocyte specification (Dorsky et al., 1998; Jin et al., 2001; Dorsky et al., 2000; 
Takeda et al., 2000; Dunn et al., 2000; Lee et al., 2004; Hari et al., 2012). Thus, the combined actions 
of early Wnt signaling and Sox10 drive expression of Mitf/Mitfa, which acts as a central node in the 
melanocyte GRN, activating numerous genes associated with all aspects of melanocyte differentiation 
(Cheli et al., 2010). Importantly, work in zebrafish has shown that a majority of neural crest cells 
express mitfa transiently, but only a subset form melanocytes (Curran et al., 2010). Thus maintenance 
of mitfa expression in a subset of neural crest cells is an important, but under-appreciated, aspect of 
melanocyte development and, indeed, likely represents a crucial part of the molecular basis for 
melanocyte fate commitment; cells in which mitfa expression is not maintained adopt alternative 
neural crest fates. 
 
As a first step in understanding how this GRN results in stable maintenance of melanocyte 
differentiation, we used a systems biology approach, taking advantage of the zebrafish model to allow 
rapid iterative cycles of mathematical modelling and biological testing of a core melanocyte GRN 
(Greenhill et al., 2011). Three cycles of this approach resulted in an expanded core network that 
incorporated a number of hypothetical components for which we also provided experimental support 
(Fig. 1A; Greenhill et al., 2011). One of these hypothetical components was a predicted Factor Y that 
enabled stabilisation of melanocyte differentiation by contributing to a positive feedback loop 
regulating mitfa expression (Greenhill et al., 2011). We showed that whilst initial expression of mitfa 
is driven by Sox10, sox10 then was gradually lost from differentiating melanocytes, being 
undetectable by in situ hybridisation or whole-mount immunofluorescence by c. 50 hours post 
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 5 
fertilisation (hpf). Importantly, we showed that continuing sox10 expression is not required for 
melanocyte differentiation and indeed, may even delay this process. In the Greenhill study we showed 
that Mitfa itself contributed to maintenance of mitfa expression, but left the identity of other possible 
components of the feedback loop unknown.  
 
The canonical Wnt pathway functions via regulation of nuclear β-catenin levels; Wnt protein binding 
to its transmembrane receptor, Frizzled, displaces glycogen synthase kinase-3β (GSK3β) from the 
destruction complex, preventing degradation of β-catenin in the cytoplasm, and resulting in elevated 
β-catenin levels in the nucleus where it functions as a transcriptional activator in co-operation with a 
co-activator, Lef-1 (Kofahl and Wolf, 2010, Barker, 2008). Canonical Wnt signaling drives fate 
specification of melanocytes via Tcf/Lef binding to mitfa regulatory elements (Dorsky et al., 1998; 
Dorsky et al., 2000; Takeda et al., 2000; Jin et al., 2001; Hari et al., 2012; Dunn et al., 2000; Lee et al., 
2004) although the relevant Frizzled receptor remains elusive (Nikaido et al., 2013). In melanocyte 
fate specification, Wnt signaling functions in conjunction with Sox10 to drive mitfa expression; in a 
sox10 mutant, mitfa expression is not detectable and melanocytes do not form (Dutton et al., 2001), 
suggesting that Wnt signaling alone is insufficient to drive mitfa expression.  
 
Here we explore two possible modes by which Wnt signaling may also contribute to melanocyte 
maintenance: 1) by ongoing action alongside Sox10, and 2) in an Mitfa-dependent manner as a 
component of Factor Y (Figure 1A). We use a transgenic reporter line to show that Wnt signaling is 
active in melanocytes throughout both specification and differentiation phases. We then use small 
molecule stimulation of Wnt signaling showing first that it activates mitfa expression and is rate-
limiting for melanocyte fate specification. We then use this approach to show that stimulating Wnt 
signaling during melanocyte differentiation affects melanocyte morphology and arrangement 
according to the timing of treatment. These shape changes correlate with upregulation of mitfa 
expression levels in melanocytes. These mitfa expression changes are independent of Mitfa activity in 
the specification and early differentiation phases, but depend upon Mitfa activity during late 
differentiation. Conversely, using a transgenic repressor of Wnt signaling, we show that inhibition of 
Wnt signaling during melanocyte differentiation stages also results in melanocyte shape changes. This 
is consistent with our proposal that Wnt signaling contributes to an Mitfa-dependent positive feedback 
loop that maintains melanocyte differentiation, in a manner consistent with our mathematical model of 
the core melanocyte GRN.  
Results 
Firstly we asked whether Wnt signaling was active in melanocytes during differentiation. We 
examined embryos carrying the Tg(top:GFP) reporter in which expression of a destabilised GFP 
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 6 
(dGFP) is driven by a promoter containing four consensus LEF1 responsive elements (Dorsky et al., 
2002; van de Wetering et al., 1997; Korinek et al., 1997; Dorsky et al., 1998). We scored a sample of 
melanocytes from these fish throughout melanocyte differentiation (30-72 hpf), using a combination 
of immunofluorescent detection of dGFP and a low dose of PTU to partially inhibit melanisation to 
increase sensitivity. We readily detected the activation of dGFP in the tectum as previously described 
(Figure 1I; Dorsky et al., 2002). We also observed, for the first time, dGFP expression in melanocytes 
throughout the time-period examined (Figure 1B-G). At early stages the majority of melanocytes 
(78.5 %) had readily detectable dGFP expression, indicating that most cells at this stage were 
responding to a Wnt signal. At later stages, a significant proportion of cells still showed detectable 
dGFP expression, although by 72 hpf the proportion of cells was substantially lower (9 %), but this is 
likely to at least partly reflect the difficulties of detection of weak fluorescence in even partially-
melanised cells.  
Having shown that Wnt signaling remains active in melanocytes throughout their differentiation, we 
then tested the hypothesis that this Wnt signaling in melanocytes might contribute to regulation of 
their differentiation. We utilised a well-characterised GSK3β inhibitor, Bromoindirubin-3'-oxime 
(subsequently referred to as BIO), that has been used to investigate the effects of increased Wnt 
signaling in many model systems, including mammalian cardiomyocyte cell culture, melanoma cells 
(B16-F0), normal human melanocyte (NHM) cells,  mouse embryonic stem cells, and zebrafish (Moro 
et al., 2012; Alexander et al., 2014; Bellei et al., 2010; Sineva and Pospelov, 2010; Kim et al., 2010; 
Bellei et al., 2008; Tseng et al., 2006). Consistent with its activation of Wnt signaling in our treated 
embryos, BIO treatment throughout a 15-40 hpf time-window activated dGFP reporter expression in 
Tg(top:GFP) fish, both in the tectum and in the melanocytes (Figure 1K-L); importantly, this BIO-
treatment did not result in gross alterations to embryonic morphology.  
Wnt signaling has been shown to drive melanocyte specification from the neural crest in both mouse 
and zebrafish (Dorsky et al., 1998; Hari et al., 2012). As a further positive control for the efficacy of 
BIO-treatment in modifying Wnt signaling in our fish, we tested the prediction that BIO treatment in 
the correct time window would increase melanocyte specification, resulting in elevated melanocyte 
numbers. We used a shorter treatment phase, focused on 15-30 hpf (Figure 2A), the time when 
melanocyte specification is thought to occur in the head and trunk. As expected, this treatment 
resulted in significantly increased melanocyte number in the head of treated embryos compared with 
controls (Figure 2B-E). Taking advantage of the developmental gradient in these embryos, we 
examined the trunk and tail region of embryos fixed at the same stage to examine whether elevated 
melanocyte numbers might be preceded by elevated mitfa expression in melanocyte progenitors 
(premigratory neural crest cells). Consistent with our current working model of the melanocyte GRN, 
BIO-treated embryos showed increased mitfa expression in premigratory neural crest cells compared 
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 7 
with mock-treated controls (Figure 2G-J). Our data suggest that the increased mitfa reflects increases 
in both the levels of mitfa expression within a cell and the number of mitfa-expressing cells (Figure 
2D,E; compare with B,C), consistent with the predicted increase in melanocyte fate specification. 
Taken together our data support the conclusion that BIO treatment in a 15-30 hpf time-window results 
in elevated melanocyte specification through increased mitfa expression after activation of Wnt 
signaling. In addition, BIO-treated embryos show a reduction in ventrally-positioned mitfa+ cells, 
suggesting a transient inhibition of melanoblast migration. 
 
Having validated BIO-treatment as an effective method for elevating Wnt signaling, we then 
addressed our hypothesis that ongoing Wnt signaling might be important for melanocyte 
differentiation and maintenance. In this study, we divided melanocyte differentiation into early and 
late phases according to sox10 expression (Figure 3A). In the early differentiation phase (24-48 hpf) 
sox10 expression in melanocytes is decreasing but still detectable by WISH and immunofluorescence, 
whereas in the late differentiation phase (48-72 hpf), sox10 is not detectable by WISH or 
immunofluorescence (Greenhill et al., 2011). We analysed the consequences of boosting Wnt 
signaling via BIO treatment throughout the entire differentiation phase (24-72 hpf) and during each of 
the early and late phases of differentiation. Firstly, we tested whether these treatments gave any effects 
in terms of melanocyte cell number, focusing on the head region. In contrast to 15-30 hpf treatment, 
no increase in melanocyte number was observed after BIO treatment from 24-48 hpf (control, mean± 
s.d = 23.9±2.01; BIO, mean±s.d = 23.1±4.03, p=0.443), suggesting that Wnt-dependent melanocyte 
fate specification is complete in the head region by 24 hpf.  
 
Next we assessed melanocyte differentiation, looking for any changes associated with BIO-treatment 
during the differentiation phases. In these BIO-treatments, we saw distinctive morphological changes 
to melanocytes, but interestingly the phenotype differed depending upon the period of BIO treatment. 
Embryos treated during the early differentiation time window and examined at 48 hpf displayed a 
dramatic increase in cell dendricity (Figure 3C,E) compared with mock-treated controls (Figure 
3B,D). To quantitate this striking phenotype, we used Image J software to estimate the roundness 
parameter, an established formula relating cell perimeter and cell area (Figure 3F).  We found BIO-
treatment resulted in a significant increase in cell dendricity compared with mock-treated controls 
(mean+s.d: control, 2.44+ 0.43; BIO, 4.25+ 1.68, p = 0.004 (unpaired, one-tailed t-test)). Importantly, 
this change in cell shape at 72 hpf was not observed in 24-72 hpf  (Figure 3G-N) or 48-72 hpf 
treatments (data not shown) suggesting that this aspect of cell differentiation was only sensitive to 
Wnt signaling for a period between 24 and 48 hpf, and that the shape changes were only transient. 
Indeed, where embryos treated in this way were examined at both 48 hpf and 72 hpf, we saw a clear 
dendricity phenotype at 48 hpf, but this had recovered by 72 hpf (data not shown). In contrast, 
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 8 
embryos treated with BIO from 24-72 hpf showed disorganised melanocytes in the dorsal head; cells 
were more dispersed, disrupting the ‘U’ or ‘O’-shaped organisation typical of control embryos (Figure 
3G-J). Treatment during the late differentiation phase alone (i.e. from 48-72 hpf) resulted in a similar 
phenotype (data not shown). A Multi-Distance Spatial Cluster Analysis using Ripley's K-Function 
(Ripley, B.D., 1977)  was performed using spatstat package in R (Baddeley & Turner 2005) to 
quantify the decrease in patterned organisation of melanocytes in the dorsal head using comparable 
pictures of DMSO and BIO treated fish (Supp. Fig.1). We found that the Ripley’s K function confirms 
the non-random organisation of melanocytes in dorsal heads of DMSO treated embryos (scale of 
analysis of r=35 pixels). Indeed, at this scale of analysis, for eight of the ten embryos the observed K 
value was smaller than the expected K value if cells were randomly spread (Supp.Fig.1, 
A,B,C,E,G,H,J). The result of the Ripley’s K analysis performed on BIO treated embryos showed 
that, at r=35, the observed K values were found within the lower confidence envelop (in the grey area) 
of the graph meaning that cells were randomly spread in 90% of the cases in nine out of ten embryos 
(Supp.Fig1K-T). Conversely, 80% of the DMSO population shows a non-random cell organisation 
and 10% of the BIO treated population shows a non-random cell organisation. A Z-test was then 
performed to compare the two populations for cellular spatial organisation using the results of this 
analysis (at r=35, comparing « random » or « not-random »); the two populations were significantly 
different for this parameter (p-value =0.00164, p <0.01).  We conclude that treating embryos with BIO 
in the early phase of differentiation led to changes in cell shape, whereas ongoing BIO-treatment 
resulted in changed melanocyte arrangement. 
 
Our working model of the melanocyte GRN predicted that mitfa transcription would be increased in 
response to activation of Wnt signaling. Using quantitative RT-qPCR, we saw a BIO-dependent 
increase in mitfa transcript levels after each of the treatment windows (Figure 4A). mitfa expression 
was increased by around five fold in embryos treated from both 24-48 hpf and 48-72 hpf whereas a 
nine-fold increase was observed in embryos treated from 24-72 hpf. Combining these data with the 
melanocyte phenotype changes observed above, we suggest that elevated mitfa expression can have 
distinct effects depending upon whether cells are in a plastic progenitor state (fate specification phase) 
or are committed to the melanocyte fate (differentiation phase). 
 
Our  model (Figure 1A) proposes two modes for Wnt action, one in conjunction with Sox10 and thus 
unlikely to be significant beyond 48 hpf when sox10 expression in melanocytes is lost (Greenhill et 
al., 2011), and one as Factor Y, where it would function as part of a positive-feedback loop with Mitfa, 
and thus would be dependent upon active Mitfa. To test whether the increase in mitfa expression 
observed in BIO-treated embryos was 1) specific for melanocytes and 2) Mitfa-dependent, we used 
whole mount in situ hybridisation and RT-qPCR to assess mitfa expression in BIO treated mitfaw2 
mutants (Figure 4B-H). The mitfa
w2 
mutant is a functional null allele, but expression of mitfa 
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 9 
transcripts can be assessed by in situ hybridisation (Johnson et al., 2010). In all cases, mitfa expression 
was restricted to cells with the morphology and distribution consistent with them being neural crest or 
melanocyte lineage cells, consistent with a cell-autonomous response. Importantly, BIO-treatment of 
mitfa
w2
 mutants in a 15-30 hpf window (i.e. during cell specification, when sox10 is relatively strongly 
expressed in the melanocyte lineage) resulted in increased mitfa expression (Figure 4H), most clearly 
seen as increased numbers of cells expressing relatively high levels of mitfa, at 30 hpf compared with 
mock-treated embryos (Figure 4B,C). A 24-48 hpf BIO-treatment, assessed at 48 hpf, showed an 
elevated level of mitfa expression in mitfa
w2 
mutants, at least in the dorsal tail (Figure 4D,E). In 
contrast, BIO-treatment in a 24-72 (data not shown) or 48-72 hpf window (Figure 4F,G), assessed at 
72 hpf, did not show elevated mitfa transcription in these mitfa
w2
 mutants (Figure 4H), suggesting that 
the Wnt-mediated effect is Mitfa-dependent. Quantitation of mitfa expression levels using RT-qPCR 
confirmed the significant increase in mitfa expression after 15-30 hpf treatment even in mitfa
w2 
mutants, and the absence of a significant response after the 24-72 and 48-72 hpf time-windows. Our 
quantitative assay did not detect the change after a 24-48 hpf time-window: although consistently 
detectable by the semi-quantitative whole-mount in situ hybridisation technique, which has the 
advantage of assessing individual cells in different spatial domains, this signal is apparently masked 
by the general signal coming from the head and trunk.  We conclude that Wnt inputs on mitfa 
expression act initially through the Sox10-dependent mechanism, but then switch to functioning 
through a Sox10-independent, Mitfa-dependent positive feedback loop. 
 
As a complement to these gain-of-function studies, we tested the effects of loss of Wnt signaling 
activity during melanocyte differentiation using a conditional activation of the dominant negative T-
cell Factor 3 (Tcf3) in transgenic zebrafish carrying Tg(hsp70l:tcf3-deltaC-GFP) (Martin and 
Kimelman, 2012). As before, we tested the functionality of our experimental system by inducing heat-
shock during the specification phase of melanocyte development, from 15 to 28 hpf, and assessing 
first activation of GFP fluorescence and expression of Wnt signaling targets such as mitfa, by RT-
qPCR. Both activation of GFP and downregulation of mitfa expression were observed after heat-shock 
(data not shown). To assess the requirement for ongoing Wnt signaling in melanocyte differentiation, 
we heat-shocked embryos at each of four timepoints, 29 hpf, 36 hpf, 48 hpf, and 62 hpf before 
assessing melanocyte phenotypes in the dorsal head at 73 hpf. Two populations of embryos could be 
distinguished by the level of activation of GFP, one where embryos showed strong GFP fluorescence 
and the second population showing weak GFP fluorescence; we note that in almost all cases 
melanocytes were abundant, indicating that survival of melanocytes was usually not affected, 
although in a subset of the fish exhibiting strong GFP, melanocyte number was visibly reduced. In the 
first population (strong inhibition of Wnt signaling) melanocyte melanisation, apparent morphology 
and patterning were all abnormal, but since the gross anatomy of the embryos was also affected, these 
melanocyte phenotypes were not quantitated. However, we noticed that a subset of melanocytes in 
Page 9 of 65 Pigment Cell & Melanoma Research Proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 10 
each fish was abnormally rounded, melanisation was always reduced and these cells were abnormally 
patterned (Supp. Fig. 2). In the second population (weak inhibition of Wnt signaling), melanocyte 
morphology was more normal, but their patterning was modified compared to non heat-schocked 
siblings (Figure 5). We observed enhanced clustering of melanocytes, particularly in the posterior 
region of the dorsal head (Figure 5B,D,F,H, blue arrow). Again, we used Multi-Distance Spatial 
Cluster Analysis using Ripley's K-Function (Ripley, B.D. (1977)) to quantify the change in patterned 
organisation of melanocytes in the dorsal head using comparable pictures (Supp. Fig. 3). This analysis 
showed that whereas 90% of the non-heat-shocked Tg(hsp70l:tcf3-deltaC-GFP) embryos showed 
“non-random” pattern, 70 % of the heat-shocked Tg(hsp70l:tcf3-deltaC-GFP) embryos showed loss 
of organisation (« random » cell organisation – the combination of the clustered melanocytes in the 
posterior head and the unclustered melanocytes in the anterior head are together scored by the 
algorithm as more randomly organised using this scale of analysis)(scale of analysis of r=50 pixels). A 
Z-test comparing the two populations for cellular spatial organisation using the results of this analysis 
(at r=50, comparing « random » or « not-random ») showed they were significantly different for this 
parameter (p-value = 0.00244, p <0.01). We conclude that inactivating Wnt signaling during 
melanocyte differentiation in Tg(hsp70l:tcf3-deltaC-GFP) using heat shock led to significantly 
increased clustering of melanocytes in the posterior part of the dorsal head. We note that this loss-of-
function phenotype is complementary to the gain-of-function phenotype using drug treatment, 
suggesting that Wnt signaling has a consistent impact on melanocyte differentiation in zebrafish in 
vivo.  
 
We used the mathematical modelling approach we developed before (Greenhill et al., 2011) to assess 
the effects of including Wnt signaling (Supp. Fig. 3A). We incorporated Wnt signaling in both fate 
specification and differentiation phases by assuming Wnt expression to activate β-catenin/Lef-1 
(abbreviated as T), coupled in turn with an AND gate to Sox10 during specification, and by another 
AND gate to Mitfa during commitment. For such a highly migratory cell-type, melanocyte fate 
specification (in/near the dorsal neural tube) and melanocyte differentiation (during dispersion and in 
post-migratory locations) are usually anatomically distinct and, given the complexity of Wnt 
expression patterns, thus are intuitively likely to involve distinct Wnt family members. Thus, we 
postulated two independent Wnt signals, one (WntA) acting in an early, but transient, time window 
lasting to approximately 30 hpf, and another (WntB) beginning at that latter time point and extending 
throughout differentiation. We also assumed a threshold level of T required to trigger a response from 
the AND gate between Sox10 and T (Supp. Fig.3A,B), and a threshold level of Mitfa to avoid 
accidental activation of the Mitfa feedback loop (see Greenhill et al., 2011). As in Greenhill et al. 
(2011) one of the key outcomes used to judge the appropriateness of the subsequent simulations was 
that mitfa expression initially rose, and then was maintained at a substantial level. Indeed, under 
normal conditions our revised model results in expression profiles comparable to those of the original 
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Greenhill Model C (Greenhill et al., 2011). Moreover, modelling the effects of mutating the two Wnt 
signals independently behave as expected intuitively (Supp. Fig. 3C,D). In particular, in the absence 
of the first Wnt signal, WntA, melanocyte specification fails and mitfa expression remains absent 
(Supp. Fig. 3C); likewise, in the absence of the second Wnt signal, WntB, mitfa expression peaks 
transiently before disappearing rapidly, so that maintenance of the differentiated state fails (Supp. Fig. 
3D). Currently, Wnt8 has been proposed as an inducer of neural crest in zebrafish (Lewis et al., 2004), 
but knowledge of the Wnt signals underlying melanocyte development in fish is very limited, 
although Wnt8 has been shown not to be critical (Dorsky et al., 1998; Lewis et al., 2004); a testable 
prediction of our modelling is that two distinct Wnt signals drive early melanocyte fate specification 
versus later maintenance of differentiation.  
 
We then assessed in silico the effect of increasing Wnt signaling strength in each of the specification 
and (early, late and full) differentiation phases. We did this by modifying the amount of WntA and 
WntB driving expression of T, and simulating accordingly the GRN response. We modelled the 
derepression of the Wnt signal due to the action of the BIO-treatment as a linear increase in time of 
WntA/B. As a consequence we expected the elevated expression of mitfa induced by BIO to be 
proportional to the duration of the BIO-treatment. Indeed, by choosing parameter values compatible 
with values in the literature (see Materials and Methods), the simulations show a relative increase of 
Mitfa expression in response to BIO compatible with the experimental data (Fig. I). In particular we 
show that when BIO is applied for the same amount of time (namely in the time windows 24-48hpf 
and 48-72hpf) the increase in mitfa is approximately the same. In contrast, when BIO is applied 
between 24-72 hpf, our simulations show a larger mitfa increase, roughly comparable with the 
observed linear dependency. Thus, our revised model with its more precise delineation of the roles of 
Wnt signals at different phases in melanocyte development continues to correspond well to the key 
experimental observations in vivo. 
 
Our observation that elevated Wnt signaling in the specification phase results in more cells becoming 
melanocytes is readily accounted for by the model through the threshold on T. The likelihood of an 
mitfa-expressing cell maintaining mitfa expression and thus differentiating into a melanocyte depends 
on T being above this threshold in the specification phase. In a population of cells, we expect 
stochastic variations in the levels of WntA (and hence T) will result in this condition not being 
satisfied in some cells. If BIO is applied early, T levels are enhanced, and therefore during the 
specification phase (i.e. prior to commitment) the proportion of cells proceeding successfully towards 
the melanocyte state is predicted to increase. In contrast, if BIO is only applied later, T levels during 
the earlier specification window are unaffected, so no change in the final number of melanocytes is 
predicted, in agreement with our experimental data.   
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Discussion 
 
We conclude that in addition to the established role for Wnt signaling in melanocyte specification 
from the neural crest, Wnt signaling has an ongoing influence on melanocyte differentiation at least 
until 72 hpf. By using a transgenic reporter strain we demonstrated that Wnt signaling remained 
detectable in differentiated melanocytes until 72 hpf at least. We then used BIO to assess the effects of 
increased Wnt signaling on melanocyte development in zebrafish embryos, showing that such 
treatment resulted in elevated mitfa expression in the neural crest and melanocyte lineage cells. 
Interestingly, we observed defects in melanocyte morphology with an increase in cell dendricity at 48 
hour post fertilisation (hpf) and altered cell organisation at 72 hpf. We complemented these gain-of-
function studies with a loss-of-function approach, using a conditional dominant negative transgenic 
line to inhibit Wnt signaling activity during melanocyte differentiation phases. Importantly, our data 
showed that this resulted changes in melanocyte morphology (when dnTcf3 strongly expressed), 
resulting for example in enhanced clustering of melanocytes in the posterior head.  This study 
demonstrates for the first time a function for Wnt signaling in zebrafish melanocytes, beyond the well-
known role in melanocyte fate specification, showing that it is important for multiple aspects of 
melanocyte differentiation. We note that our data indicates that the mode of Wnt signaling input 
changes from an Mitfa-independent/Sox10-dependent early role to an Mitfa-dependent/Sox10-
independent later role, suggesting that Wnt signaling at late stages becomes incorporated into the 
melanocyte maintenance (Factor Y) role postulated in our earlier work. We have revised our working 
model of the core GRN of melanocyte development in zebrafish to incorporate these new data (Figure 
4J). It is likely that Wnt signaling has a similar role in mammalian melanocytes since GSK3β 
inhibition results in upregulation of MITF expression and differentiation in normal human 
melanocytes, at least in cell culture (Bellei et al., 2008).  
 
 
Although we show here that Wnt signaling continues to influence melanocyte differentiation, our 
gain-of-function experiments do not cause  obvious effects on melanisation. However, we note that 
our modelling data (Supp. Fig. 3E,F) indicates that this may be quantitatively relatively subtle (e.g. 
for dct in curves shown), so our failure to detect such an effect in vivo may be simply due to lack of 
sensitivity in our assay. A study of normal human melanocytes in tissue culture showed that GSK3β 
inhibition stimulated melanogenesis through activation of MITF (Bellei et al., 2008). In contrast, in 
our loss-of-function experiments, those embryos showing highest levels of GFP and in which Wnt 
signaling was presumably most inhibited, showed a pronounced reduction in both melanin levels and 
defects in apparent cell morphology. Thus, it seems that Wnt signaling is important for all aspects of 
melanocyte differentiation, consistent with its effects on expression of mitfa. 
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The role for Wnt/β-catenin signaling in melanocyte specification through induction of Mitf expression 
is conserved in fish and mammals (Dorsky et al., 2000; Takeda et al., 2000). Our work showing that 
inhibition of GSK3-β using BIO stimulates melanoblast specification (mitfa expression) adds further 
support to this conclusion. Importantly, no increase in melanocyte cell number in the dorsal head was 
observed after 24-72 hpf treatments suggesting that melanocyte specification from neural crest cells 
does not extend much beyond 24 hpf. Furthermore, our time window studies showed that treatment 
from 15-30 hpf was sufficient to generate elevated numbers of head melanocytes that persist until at 
least 72 hpf, whereas treatment in a 24-48 hpf window did not. These data indicate, for the first time 
to our knowledge, that commitment to the melanocyte fate in zebrafish  (at least for melanocytes in 
the head region that arise in the embryo) has occurred by c. 30 hpf. As explained above, melanocyte 
specification reflects maintenance of mitfa expression in NCCs, so our data suggest that this process 
is limited by Wnt signaling. 
  
Our data demonstrate intriguing Wnt-dependent effects on melanocyte morphology and organisation. 
An in vitro study of normal human epidermal melanocytes demonstrated that increased and decreased 
levels of active β-catenin resulted in increased and decreased cell dendricity respectively (Kim et al., 
2010). They further showed that this resulted from activation of distinct downstream modulators, 
PKCf and PKCd, respectively (Kim et al., 2010). They showed that overexpression of PKCf resulted 
in the decrease of protein levels for Rac1 and Cdc42 and consequently a reduction of dendrite 
formation in melanocytes, while overexpression of PKCd led to increase of Rac1 and Cdc42 and an 
increase in melanocyte dendrites. We show here that elevated Wnt signaling results in increased mitfa 
expression and increased dendricity, suggesting a causal link between mitfa expression levels and cell 
shape. This idea is strongly supported by earlier studies in Xenopus embryos showing that increased 
X-mitfa expression resulted in increased melanocyte dendricity and cell dispersal (Kumasaka et al., 
2005; Kawasaki et al., 2008). Further studies will be required to test whether Wnt signaling in 
zebrafish causes increased melanocyte dendricity through a pathway of mitfa-dependent activation of 
PKCd, elevated levels of activated Rac and Cdc42, and consequent modifications of the actin 
cytoskeleton. 
 
In summary, our work defines two phases of Wnt signaling involvement in zebrafish melanocyte 
development in vivo, both of which are likely conserved in mammals. Recent analysis showed that the 
two transcription factors Tfap2a and Tfap2e are required for early melanocyte differentiation, through 
both maintenance of kit expression and another mechanism still to be defined (Van Otterloo et al., 
2010). It will be of interest to assess whether these roles for Tfap2 factors extends to ongoing 
maintenance of the differentiated state and, if so, the extent to which Wnt signaling and Tfap2/Kit 
function are integrated in this system. 
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Figure legends 
Figure 1.  
 Ongoing Wnt signaling is detectable in differentiating melanocytes. 
 (A) Diagram of working model for melanocyte core GRN (modified from Greenhill et al., 2011). 
Note two inputs from Wnt signaling on mitfa expression, one well-established role acting alongside 
Sox10 driving melanocyte fate specification, and hypothetical role explored here as part of a positive 
feedback loop also involving Mitfa itself. B-G) Wnt signaling in differentiating melanocytes was 
assessed by scoring samples of melanocytes for detection of dGFP by immunofluorescence in 
Tg(top:GFP) transgenic embryos from 30-72 hpf. GFP-positive melanocytes (arrows) are shown by 
immunofluorescence (B,D,F) and DIC (C,E,G) to show melanin pigment. At each stage, 30 
melanocytes in each of 15 embryos were assessed for GFP expression, in the dorsal head and 
throughout the dorsal and lateral trunk; numbers show the percentage of melanocytes expressing GFP 
(mean ± s.d) at corresponding stages (n = 450 per stage). H) Schematic showing timing of BIO 
treatment used. I-L) BIO-treatment enhances activity of Tg(top:GFP) reporter. BIO-treatment from 15 
hpf to 40 hpf dramatically enhances dGFP expression (red arrows) in the tectum of treated (K) 
compared with mock-treated controls (I) and also increases dGFP signal in melanocytes of 
Tg(top:GFP) embryos (BIO-treated (L) compared with mock-treated control (J)). All images, lateral 
views using confocal microscopy.  EM, embryo medium; e: eye; T: tectum. Scale bars: B-G) 10 µm; 
I-L) 100 µm.  
 
Figure 2. 
Elevated Wnt signaling in melanocyte specification time window increased numbers of 
melanocytes. A) Schematic showing timing of BIO treatment or control mock-treatment (DMSO 
alone) used. B-E) Lateral views of the trunk of live 30 hpf zebrafish embryos showing melanocytes 
(red arrows); note increased number in both anterior (D) and posterior trunk (E) of embryos treated 
with 5 µM BIO compared with control DMSO treated embryos (B,C respectively). F) Quantitation of 
increased melanocyte number in heads of BIO-treated embryos (mean ± s.d.; control, 13 ± 2.1; BIO, 
32 ± 5.3, p<10
-6
) (n= 20; *** indicates significant difference between treated and mock-treated; 
unpaired, one-tailed t-test). G-J). Lateral views of posterior trunk (G,I) and close-up of anterior tail 
(H,J) of 30 hpf zebrafish embryo in situ hybridisations to show mitfa expression in embryos treated 
with BIO (I,J) or DMSO control (G,H). In the DMSO control embryos (G,H) discontinuous mitfa 
expression is observed in the dorsal region (blue arrows show discontinuities of the signal), whereas 
in the BIO treated embryos (I,J) mitfa expression is continuous throughout the dorsal region (red 
arrows). Images show representative phenotypes (n=20 per treatment). Scale bar: 100 µm.  
 
Figure 3: Elevated Wnt signaling in melanocyte differentiation time window alters melanocyte 
morphology. A) Schematic of melanocyte differentiation BIO-treatment time-windows. B-E) 
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Activation of Wnt signaling in early differentiation period (24-48 hpf) increases melanocyte 
dendricity and dispersion. Lateral view at 48 hpf of head of live embryos treated with control DMSO 
(B) or BIO (C) from 24-48 hpf. Panels D and E show enlargements of head melanocytes from 
embryos in B and C respectively. F) Quantitation of dendricity: the cell roundness parameter was 
calculated for each melanocyte as R = P2 ⁄ 4∏A, where A is the cell area and P the cell perimeter, 20 
cells were investigated (n=20) in 10 different embryos for each condition. A score of R=1.0 represents 
a perfectly round melanocyte; increased R values represent increased dendricity. Control, R=2.44 ± 
0.43, BIO R= 4.25 ± 1.68, p = 0.004, t-test result, p-value<0.01 (**). G-J) Elevated Wnt signaling 
throughout full differentiation or during late differentiation window only affects melanocyte 
organisation. Red line in G indicates the dorsal head melanophores which usually approximate an O- 
or U-shaped pattern, although often with extra branches as in this specific example. Dorsolateral view 
at 72 hpf of heads of live embryos treated with control DMSO (G,I,K,M) or BIO (H,J,L,N) from 24-
72 hpf shown. Note that embryos treated in only Late Differentiation window (48-72 hpf) show 
equivalent phenotype (data not shown). Embryos shown are representative of samples examined 
(n=160 zebrafish embryos for each treatment). Scale bars: 100 µm (B,D,G,I). 
 
Figure 4: Positive feedback between Wnt signaling and Mitfa during late differentiation phase 
of melanocyte development. A) Quantitation of mitfa expression by RT-qPCR showing significantly 
increased levels in BIO-treated embryos compared with untreated controls; data are expressed as 
percentage of mock-treated controls (control mitfa level = 100 % transcripts (red line on graph)). 
Gene expression was investigated in 10 samples consisting of the trunk and tail of 50 embryos for 
each condition and in triplicate, after normalisation to the stable expression of a reference house-
keeping gene, gapdh. All treatments caused significant increase of mitfa expression (t-test, two- tailed: 
24-48 hpf, 535±7.1 (p= 0.00087); 48-72 hpf, 496±9.8(p= 0.0085); 24-72 hpf, 872±32.1 (p = 
0.000092). ***, p-value<0.001). B-G) Activating Wnt signaling after 48 hpf does not affect mitfa 
expression in mitfa
w2
 mutant embryos during melanocyte differentiation. Lateral views of trunk 
showing in situ hybridisation for mitfa expression in mitfa mutant fish. mitfa mutant embryos treated 
with BIO in the melanocyte specification phase (15-30 hpf) (C) showed increased mitfa expression 
(purple) compared to DMSO-treated embryos (B). Similarly, mitfa mutant embryos treated with BIO 
in the melanocyte early differentiation phase (24-48 hpf) (E) showed increased mitfa expression in tail 
dorsal stripe melanocytes compared to DMSO-treated embryos (D). In contrast, mitfa mutant embryos 
treated with BIO throughout the late melanocyte differentiation phase (48-72 hpf) (G) did not show 
increased mitfa expression compared to DMSO-treated embryos (F) at 72 hpf. 40 zebrafish embryos 
were investigated for each condition; BIO-treated and matched control embryos were processed for in 
situ hybridisation in parallel and under identical conditions. H) Quantitation of mitfa expression by 
RT-qPCR showing significantly increased levels in BIO-treated embryos at 30 hpf compared with 
untreated controls but not at 48 hpf nor at 72 hpf; data are expressed as percentage of mock-treated 
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controls (control mitfa level = 100 % transcripts (red line on graph)). Gene expression was 
investigated in triplicate, after normalisation to the stable expression of a reference house-keeping 
gene, gapdh. Only 15-30 hpf treatment caused significant increase of mitfa expression (t-test, two- 
tailed: 15-30 hpf, 160.39±7.27 (p=0.0020); 24-48 hpf, 108.15±7.9 (p= 0.0675); 24-72 hpf, 104.6±8.36 
(p= 0.544); 24-72 hpf, 86.14±8.96 (p = 0.0831). **, p-value<0.01). I) The effect of the three BIO-
treatments applied in the 24-48, 48-72 and 24-72 hpf time windows is shown on Mitfa only as 
compared to the case of no treatment. The 24-48 and 48-72 hpf BIO-treatments induce an 
approximately equal increase of Mitfa as measured at the end of the treatment. J) Revised GRN 
model. Scale bars: 100 µm  
 
Figure 5: Inactivation of Wnt signalling during melanocyte differentiation enhances melanocyte 
clustering in posterior dorsal head. Tg(hsp70l:tcf3-deltaC-GFP) embryos were heat shocked at 29 
hpf, 36 hpf, 48 hpf and 62 hpf and observed at 73 hpf (B, D, F, H) and compared to control non-heat-
shocked transgenic Tg(hsp70l:tcf3-deltaC-GFP) (A, C, E, G). Note the enhanced clustering of 
melanocytes in the posterior part of the dorsal head in treated embryos (blue arrows) ; the normal 
distribution in this area in untreated controls is indicated by red arrows. Heat shock activation of Wnt 
inhibition consistently resulted in smaller heads and eyes. Scale bars: 100 µm. 
 
Supplemental data 
Supplementary Figure 1: Ripley’s K function analysis shows significant decrease in melanocyte 
organisation in BIO-treated embryos compared to DMSO-treated embryos at 72 hpf. 
Ripley’s K function analysis was performed on 10 DMSO treated embryos (A-J) and 10 BIO 
treated embryos (K-S). The expected values for K if the cells are randomly spread are 
represented by the red dotted line on the graph; the grey area corresponds to area between the 
lower and higher confidence envelope/interval for values of K. Based on inspection of control 
embryos, and noting that the dorsal head melanocytes are clearly patterned, we set the scale 
of analysis to r=35 pixels (blue arrows and blue lines). Significant clustering then 
corresponds to the white zone underneath the grey area whereas significant dispersion 
corresponds to the white area above the grey area. As expected, 8 out of 10 DMSO-treated 
control embryos are scored as showing a clustered pattern (below the grey area; embryos A-
E,G,H,J).  In contrast, Ripley’s K function analysis performed on BIO treated embryos 
showed that the observed K values were found within the lower confidence envelope (in the 
grey area) of the graph in nine out of ten embryos (embryos K-S), so that cells appeared 
randomly dispersed in 90% of the cases.  
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Supplementary Figure 2: Strong expression of a dntcf3 transgene results in poor melanocyte 
differentiation. Transgenic Tg(hsp70l:tcf3-deltaC-GFP) embryos that were heat shocked at each of 
29, 36, 48 and 62 hpf and which showed strong GFP expression (A,C,E) demonstrate a strong 
melanocyte phenotype including reduced melanisation and more rounded shape (red arrowheads) at 
73 hpf compared to non-heat-shocked control transgenic embryos (B,D,F). Scale bars: 100 µm. 
 
Supplemental Figure 3: Ripley’s K function analysis shows significant decrease in melanocyte 
organisation when Wnt signalling is impaired in dntcf3 transgenic embryos at 72 hpf. 
Ripley’s K function analysis was performed on 10 control non-heat-shocked transgenic 
Tg(hsp70l:tcf3-deltaC-GFP) embryos (A-J) and 10 heat-shocked transgenic Tg(hsp70l:tcf3-deltaC-
GFP) embryos (K-T). The expected values for K if the cells are randomly spread are represented by 
the red dotted line on the graph; the grey area corresponds to area between the lower and the higher 
confidence envelope/interval for values of K. Based on inspection of control embryos, and noting that 
the dorsal head melanocytes are clearly patterned, we set the scale of analysis to r=50 pixels (blue 
arrows and blue lines). Significant clustering then corresponds to the white zone underneath the grey 
area whereas significant dispersion corresponds to the white area above the grey area. As expected, 
eight out of ten control embryos are scored as showing a clustered pattern (below the grey area; 
embryos A-E,G,H,J).  In contrast, Ripley’s K function analysis performed on heat-shocked embryos 
showed that the observed K values were found within the lower confidence envelope (in the grey 
area) of the graph in seven out of ten embryos (embryos K-S), so that cells showed ‘lower 
organisation’ in 70% of the cases. 
 
Supplementary Figure 4:  
A) Core GRN for melanocyte differentiation activated by Wnt signaling.  Extension of Gene 
Regulatory Network as from Greenhill et al., (2011) with inclusion of β-catenin/Lef-1 (indicated in 
the diagram as T) mediated Wnt activation.  The complex β-catenin/Lef-1 is assumed to work in 
conjunction with Sox10 and Mitfa through AND gates. Two components of Wnt signaling (WntA and 
WntB) are also assumed to participate selectively in fate specification and commitment respectively. 
B) Schematic of WntA and WntB signaling. 
We show the time profile of the Wnt components, WntA and WntB, as used in this model. The first 
component is active between times 15-30 hpf and activates production of nuclear T (plotted) above 
the threshold value while the second component is active for times beyond 30 hpf and has a lower 
affinity not enough to induce a production of T above threshold. Note that although modelled here as 
differences in affinity for their receptors, exactly equivalent outcomes would result if their affinities 
were identical, but WntA and WntB expression levels differed. 
C-D) Selective failure of specification and commitment. 
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We plot the response of the GRN to either Wnt component acting alone. When only WntA is active 
(C) we have specification but only transient differentiation (Mitfa increases initially, but then decays 
to zero) while when only WntB is active (D) Mitfa production is never observed. The traces of Sox10 
(red curve), Z (orange), T (blue), Dct (dark green), Tyrp1 (brown), A (black) and Mitfa (light green) 
are plotted as a function of time (hours after fertilisation, hpf). 
E-F) Simulation of the core GRN according to the mathematical model (see Methods). 
The traces of Sox10 (red curve), Z (orange), T (blue), Dct (dark green), Tyrp1 (brown), A (black) and 
Mitfa (light green) are plotted as a function of time (hrs). Solid lines correspond to time-courses 
without BIO treatment while circles correspond to those with BIO treatment.  E) BIO treatment is 
applied between 24 and 48 hpf, Mitfa (light green circles) is amplified 2-fold at 48 hrs as compared to 
the evolution without BIO treatment (light green line) at the same time. F) BIO treatment is applied 
between 24 and 72 hpf, Mitfa (light green circles) is amplified 3-fold at 72 hrs as compared to the 
evolution without BIO treatment (light green line) at the same time.  
 
Methods 
Fish Husbandry 
Wild type (AB) and transgenic Tg(-7.2sox10:EGFP) (Carney et al., 2006) and Tg(top:GFP)) (Dorsky 
et al., 2002) and mutant mitfaw2 (Lister et al., 1999) zebrafish, Danio rerio, were kept in the aquarium 
at the University of Bath. Tg(hsp70l:tcf3-deltaC-GFP) (=w26Tg) fish (Martin and Kimelman, 2012) 
were kept in the facilities of the Department of Developmental and  Cell Biology, School of 
Biological Sciences at the University of California, Irvine. Natural crosses were set up overnight and 
embryos collected in the morning. Embryos were placed in embryo medium and grown at 28.5 °C. 
They were staged according to Kimmel et al., (1995). Where embryos were to be manipulated 
between laying and hatching we used Watchmakers’ No5 forceps to dechorionate the embryos. 
Embryos older than 15 hpf which were to be manipulated in any way were anaesthetised with Tricaine 
(Ethyl 3-aminobenzoate methanesulphonate, 4 g/L stock, final concentration approximately 0.2 % 
v/v). Where appropriate, melanisation was inhibited using PTU (1-phenyl-2-thiourea) from 24 hpf at a 
final concentration of 0.0015 % in embryo medium. All experiments complied with institutional and 
national animal welfare laws, guidelines and policies. Procedures involving fish older than 5 dpf were 
undertaken under licence from the UK Home Office.  
 
 
BIO (2'Z,3'E)-6-Bromoindirubin-3'-oxime) treatment 
BIO (2'Z,3'E)-6-Bromoindirubin-3'-oxime):  GSK3β inhibitor (Calbiochem) was stored as a 10 mM 
stock solution in DMSO. Ten wild type or mitfaw2 mutant embryos were placed in triplicate into 6-cm 
petri dishes containing 8 ml embryo medium. All embryos were dechorionated before 10 mM BIO 
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(361550 GSK-3 Inhibitor IX, Calbiochem) in DMSO was added to each experimental dish to a final 
concentration of 5 µM; an equivalent volume of DMSO was added to the control dishes. Embryos 
were incubated under standard conditions from 15-30, 24-48, 48-72 or 24-72 hpf.   
 
Heat-shock experiment 
Tg(hsp70l:tcf3-deltaC-GFP) transgenic embryos (Martin and Kimelman, 2012) were heat shocked at 
39°C  for 12 minutes at four timepoints (29 hpf, 36 hpf, 48 hpf and 60 hpf) during melanocyte 
differentiation;  after heat-shock, embryos were assessed for GFP expression  and left to develop at 
28.8°C in incubator. Embryos were assessed for melanocyte differentiation defects at 73 hpf.  
Whole mount in situ hybridisation 
RNA in situ hybridisation was performed according to Thisse and Thisse, (2008) except probes were 
not hydrolysed and embryos were incubated at 68 °C in hybridization steps. Probes used were sox10 
(Dutton et al., 2001), mitfa (Lister et al., 1999), xdh (Parichy et al., 2000). (Plasmid and probe 
generated by T. Chipperfield and C. Nelson). 
 
RNA extraction and cDNA synthesis   
RNA was extracted from samples consisting of 50 whole embryos of each condition using TRI 
REAGENT (Sigma-Aldrich, T9424)  according to manufacturer’s instructions and purified and 
precipitated by phenol/chloroform/isoamylalcohol (25:24:1). The RNA pellet was washed in 1ml 75% 
ETOH by inverting the tube gently. A 1 µl sample was assessed for purity, integrity by gel 
electrophoresis, and concentration was measured spectrophotometrically. When required, samples 
were stored at -80°C for not more than a month. For experiment using WT embryos, first strand 
cDNA was synthesised using the Invitrogen First strand cDNA synthesis kit with Superscript III and 
oligodT (Promega), 0.5 µl random hexamers (250ng/µl) (Promega), 5 µl dNTPs (2mM) (Promega), 
7.5 µl RNA (1 µg of total RNA) were first mixed and incubated for 5 mins at 65
o
C and then at least 1 
min at 4oC. Second, 4 µl of 5X first strand buffer (Invitrogen), 1 µl of 5mM DTT, 1 µl RNAse out 
(Invitrogen) and 1 µl superscript III (Invitrogen) RTase/Mµl were added to the previous mix and left 5 
minutes at 25 oC, 60 oC minutes at 50 oC, 15 minutes at 70 oC. Finally, samples were diluted 1:5 and 
concentrations were measured spectrophotometrically. For experiments using mitfa
w2
 mutant 
embryos, RNA extraction was performed by Direct-zol™ RNA MiniPrep (Zymo Research) and the 
iScript™ Advanced cDNA Synthesis Kit (Bio-Rad) was used for reverse transcription of 1 µg RNA in 
20 µl reaction according to manufacturer’s protocol. 
 
Real-time quantitative PCR   
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.Real time quantitative PCR was performed in triplicate using SYBR Green I PCR Master Mix 
(Roche) for WT embryos and a Lightcycler II machine (Roche) was used according to the 
manufacturer’s instructions. For mitfaw2 mutant embryos, the Fast SYBR® Green Master Mix 
(ThermoFisher) was used and samples were run in triplicate using the StepOne™ System 
(ThermoFisher) according to manufacturer’s instructions. Standard curves for both gapdh and mitfa 
primers demonstrated nearly 100% efficiency (98.7% and 98.5%, correspondently). Primers were 
designed spanning an intron using Primer3 Plus software (http://www.bioinformatics.nl/cgibin/ 
primer3plus/primer3plus.cgi.). The following primers were used:  
gapdh: forward 5'ACCAACTGCCTGGCTCCT3',  
            reverse 5'TACTTTGCCTACAGCCTTGG3';  
mitfa: forward 5'CTGGACCATGTGGCAAGTTT3',  
           reverse 5'GAGGTTGTGGTTGTCCTTCT3'  
Gene expression was normalized against zebrafish gapdh expression in wild-type embryos. RT-qPCR 
data were analysed using the (∆∆Ct) method (Livak et al., 1998). Student’s t-test was performed using 
GraphPadPrism 5.0. In all tests, difference was considered significant if p<0.001. 
 
Immunofluorescence  
Embryos for immunofluorescent detection were processed following the protocol proposed by (Ungos 
et al., 2003). Embryos were fixed in 4 % Paraformaldehyde in PBS (Phosphate buffered saline, 
Oxoid) overnight at 4 °C. They were washed three times for 5 minutes in PBTriton (0.1 % Triton X-
100 Sigma-Aldrich in PBS) and three times for one hour in MilliQ water. Embryos were incubated in 
block solution (1 % DMSO, 5 % Goat/Sheep serum diluted in PBTriton) for 2 to 3 hours. They were 
then incubated at room temperature overnight in polyclonal mouse serum primary antibody 
(Polyclonal IgG Rabbit Anti-GFP Primary Antibody, Invitrogen, A11122) diluted 1:500 in block 
solution.  Embryos were washed in PBTriton once briefly and three times for one hour. They were 
incubated overnight 4 °C in Alexa Fluor 488 fluorescent anti-rabbit secondary antibody (Polyclonal 
IgG Alexa Fluor 488 donkey anti-rabbit, Invitrogen, A21206) diluted 1:200 in block solution. 
Embryos were then washed once briefly and three times for 30 minutes in PBTriton. They were stored 
in 50 % glycerol for imaging and storage.  
 
Microscopy 
Fish were mounted between bridged coverslips in methylcellulose for live embryos, anesthetized with 
0.003 % MS222 (Sigma), and in 80 % glycerol for fixed embryos. Embryos were photographed using 
a Spot digital camera (supplier) mounted on an Eclipse E800 microscope (Nikon) or Axioplan 2 
microscope (Zeiss) with DIC optics using a Spot digital camera mounted on a MZ12 microscope 
(Leica) with epi-illumination or Nikon sight DS-U1 camera (Nikon). To minimise the effects of the 
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developmental gradient along the body axis, melanocyte counts were performed on the head only, 
from the anteriormost region (forebrain) to the rear of the otic vesicle (posterior hindbrain); 
melanocytes were counted only in the region dorsal to the CNS (i.e the developing dorsal stripe). 
 
 
Dendricity measurement 
Dendricity was calculated as R (R = P2 ⁄4pA, where A is the cell area and P the cell perimeter), cell 
perimeter and area was measured using ImageJ software from images of cells taken using Eclipse 
E800 microscope (Nikon). 
Ripley’s K function analysis 
To quantify and compare melanocyte organisation in DMSO treated embryos and BIO treated 
embryos the Multi-Distance Spatial Cluster Analysis, based on Ripley's K-Function, was 
performed using R statistical software (using packages "spatstat" and "dplyr" (R Core Team (2012)).  
Melanocyte positions were determined on the dorsal head of ten treated 72 hpf embryos for each 
conditions (DMSO and BIO treated) using comparable pictures. x and y coordinates for each 
melanocyte’s position was determined using ImageJ. This data was then used to perform the 
Ripley’s K function analysis which allows testing for random partition of the cells.  
A Z-test allowed comparison of the two populations for cellular spatial organisation using the 
results of this analysis; the result was considered significant if p<0.01. 
 
Statistics 
Data were analysed by Prism 3.0 software GraphPadPrism 5.0 using unpaired t-test, α=0.05%, n=20 
and fd= (x-2), with x = number of embryo tested. 
 
Mathematical Modelling 
Following the scheme of Supp. Fig. 3A and indicating the molecular species with their initials (except 
Tyrp1, indicated with  yT )  we describe the behaviour of the GRN by the following set of ordinary 
differential equations: 
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All equations have been derived from the network scheme in Supp. Fig. 3A   by applying the rules 
explained in Greenhill et al. (2011).  In addition, here we consider β-catenin/Lef-1 (T) acting in 
conjunction with either Sox10 (S) or Mitfa (M) via an AND gate in order to activate the production of 
Mitfa itself. This means that Mitfa production is activated only when either of the two AND gates 
involving T (one with Sox10 and the other with Mitfa) is active. The AND gate with Sox10 is 
activated only when the concentration of T is larger than a given thresholdT .  A second threshold M
on the concentration of Mitfa is operative also on the self-activating loop of Mitfa. 
 
The core of the network corresponds to what has already been modelled in Greenhill et al. (2011) with 
the addition of Wnt signaling. Wnt is assumed to have two components WntA (WA in the equations 
above) and WntB (WB) both activating transcription factor β-catenin/Lef-1 (indicated as T in the 
equations). The binding and unbinding dynamics of Wnt is assumed to be fast as compared to the 
other network reactions and therefore Wnt is assumed to be equilibrated at any time. The first 
component WntA is present only for a transient time between 15 and 30 hpf, while the second 
component WntB starts at 30 hpf and remains active throughout the whole differentiation process (see 
Supp. Fig. 3B).  When these two components act together they guarantee specification and 
commitment of the melanocytes lineage. If only WntA is present then we have specification but no 
commitment (see Supp. Fig. 3C) while if only WntB is present no specification is observed (Supp. 
Fig. 3D). Notice that this mechanism relies on the presence of a threshold on the activation of the 
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AND gate between Sox10 and T which prevents the production of Mitfa and therefore the activation 
of Mitfa’s feedback loop. In order to simulate the BIO-treatment we added a correction GBIO to the WA 
and WB components, which amounts to a time-linear increase in Wnt when the BIO-treatment is 
applied between t
S
BIO and t
E
BIO (times of start and end of the treatment respectively) and is one when 
there is no BIO-treatment.  Parameter values for the model are:  

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These values are chosen in accordance with measured values from the literature (Jin & Liao, 1999, 
Schwanhausser et al., 2011 and Eden et al., 2011 for Sox10, Jao et al., 2013 for Mitfa) and within 
similar ranges as in Greenhill et al. (2011) for those unknown.  We have assumed the same affinity for 
the two Wnt components and larger concentration for WA but the opposite assumption (different 
affinity and same concentration) would lead to the same results.  A slower decay rate for Mitfa than 
the one used in Greenhill et al., 2011 produced a better quantitative agreement with BIO-treatment 
results. 
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Figure 1.  
Ongoing Wnt signaling is detectable in differentiating melanocytes.  
(A) Diagram of working model for melanocyte core GRN (modified from Greenhill et al., 2011). Note two 
inputs from Wnt signaling on mitfa expression, one well-established role acting alongside Sox10 driving 
melanocyte fate specification, and hypothetical role explored here as part of a positive feedback loop also 
involving Mitfa itself. B-G) Wnt signaling in differentiating melanocytes was assessed by scoring samples of 
melanocytes for detection of dGFP by immunofluorescence in Tg(top:GFP) transgenic embryos from 30-72 
hpf. GFP-positive melanocytes (arrows) are shown by immunofluorescence (B,D,F) and DIC (C,E,G) to show 
melanin pigment. At each stage, 30 melanocytes in each of 15 embryos were assessed for GFP expression, 
in the dorsal head and throughout the dorsal and lateral trunk; numbers show the percentage of 
melanocytes expressing GFP (mean ± s.d) at corresponding stages (n = 450 per stage). H) Schematic 
showing timing of BIO treatment used. I-L) BIO-treatment enhances activity of Tg(top:GFP) reporter. BIO-
treatment from 15 hpf to 40 hpf dramatically enhances dGFP expression (red arrows) in the tectum of 
treated (K) compared with mock-treated controls (I) and also increases dGFP signal in melanocytes of 
Tg(top:GFP) embryos (BIO-treated (L) compared with mock-treated control (J)). All images, lateral views 
using confocal microscopy.  EM, embryo medium; e: eye; T: tectum. Scale bars: B-G) 10 µm; I-L) 100 µm.  
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Figure 2. Elevated Wnt signaling in melanocyte specification time window increased numbers of 
melanocytes. A) Schematic showing timing of BIO treatment or control mock-treatment (DMSO alone) used. 
B-E) Lateral views of the trunk of live 30 hpf zebrafish embryos showing melanocytes (red arrows); note 
increased number in both anterior (D) and posterior trunk (E) of embryos treated with 5 µM BIO compared 
with control DMSO treated embryos (B,C respectively). F) Quantitation of increased melanocyte number in 
heads of BIO-treated embryos (mean ± s.d.; control, 13 ± 2.1; BIO, 32 ± 5.3, p<10-6) (n= 20; *** 
indicates significant difference between treated and mock-treated; unpaired, one-tailed t-test). G-J). Lateral 
views of posterior trunk (G,I) and close-up of anterior tail (H,J) of 30 hpf zebrafish embryo in situ 
hybridisations to show mitfa expression in embryos treated with BIO (I,J) or DMSO control (G,H). In the 
DMSO control embryos (G,H) discontinuous mitfa expression is observed in the dorsal region (blue arrows 
show discontinuities of the signal), whereas in the BIO treated embryos (I,J) mitfa expression is continuous 
throughout the dorsal region (red arrows). Images show representative phenotypes (n=20 per treatment). 
Scale bar: 100 µm.  
Figure 2  
240x231mm (299 x 299 DPI)  
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Figure 3: Elevated Wnt signaling in melanocyte differentiation time window alters melanocyte morphology. 
A) Schematic of melanocyte differentiation BIO-treatment time-windows. B-E) Activation of Wnt signaling in 
early differentiation period (24-48 hpf) increases melanocyte dendricity and dispersion. Lateral view at 48 
hpf of head of live embryos treated with control DMSO (B) or BIO (C) from 24-48 hpf. Panels D and E show 
enlargements of head melanocytes from embryos in B and C respectively. F) Quantitation of dendricity: the 
cell roundness parameter was calculated for each melanocyte as R = P2 ⁄ 4∏A, where A is the cell area and 
P the cell perimeter, 20 cells were investigated (n=20) in 10 different embryos for each condition. A score of 
R=1.0 represents a perfectly round melanocyte; increased R values represent increased dendricity. Control, 
R=2.44 ± 0.43, BIO R= 4.25 ± 1.68, p = 0.004, t-test result, p-value<0.01 (**). G-J) Elevated Wnt 
signaling throughout full differentiation or during late differentiation window only affects melanocyte 
organisation. Red line in G indicates the dorsal head melanophores which usually approximate an O- or U-
shaped pattern, although often with extra branches as in this specific example. Dorsolateral view at 72 hpf 
of heads of live embryos treated with control DMSO (G,I,K,M) or BIO (H,J,L,N) from 24-72 hpf shown. Note 
that embryos treated in only Late Differentiation window (48-72 hpf) show equivalent phenotype (data not 
shown). Embryos shown are representative of samples examined (n=160 zebrafish embryos for each 
treatment). Scale bars: 100 µm (B,D,G,I).  
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Figure 4: Positive feedback between Wnt signaling and Mitfa during late differentiation phase of melanocyte 
development. A) Quantitation of mitfa expression by RT-qPCR showing significantly increased levels in BIO-
treated embryos compared with untreated controls; data are expressed as percentage of mock-treated 
controls (control mitfa level = 100 % transcripts (red line on graph)). Gene expression was investigated in 
10 samples consisting of the trunk and tail of 50 embryos for each condition and in triplicate, after 
normalisation to the stable expression of a reference house-keeping gene, gapdh. All treatments caused 
significant increase of mitfa expression (t-test, two- tailed: 24-48 hpf, 535±7.1 (p= 0.00087); 48-72 hpf, 
496±9.8(p= 0.0085); 24-72 hpf, 872±32.1 (p = 0.000092). ***, p-value<0.001). B-G) Activating Wnt 
signaling after 48 hpf does not affect mitfa expression in mitfaw2 mutant embryos during melanocyte 
differentiation. Lateral views of trunk showing in situ hybridisation for mitfa expression in mitfa mutant fish. 
mitfa mutant embryos treated with BIO in the melanocyte specification phase (15-30 hpf) (C) showed 
increased mitfa expression (purple) compared to DMSO-treated embryos (B). Similarly, mitfa mutant 
embryos treated with BIO in the melanocyte early differentiation phase (24-48 hpf) (E) showed increased 
mitfa expression in tail dorsal stripe melanocytes compared to DMSO-treated embryos (D). In contrast, 
mitfa mutant embryos treated with BIO throughout the late melanocyte differentiation phase (48-72 hpf) 
(G) did not show increased mitfa expression compared to DMSO-treated embryos (F) at 72 hpf. 40 zebrafish 
embryos were investigated for each condition; BIO-treated and matched control embryos were processed for 
in situ hybridisation in parallel and under identical conditions. H) Quantitation of mitfa expression by RT-
qPCR showing significantly increased levels in BIO-treated embryos at 30 hpf compared with untreated 
controls but not at 48 hpf nor at 72 hpf; data are expressed as percentage of mock-treated controls (control 
mitfa level = 100 % transcripts (red line on graph)). Gene expression was investigated in triplicate, after 
normalisation to the stable expression of a reference house-keeping gene, gapdh. Only 15-30 hpf treatment 
caused significant increase of mitfa expression (t-test, two- tailed: 15-30 hpf, 160.39±7.27 (p=0.0020); 24-
48 hpf, 108.15±7.9 (p= 0.0675); 24-72 hpf, 104.6±8.36 (p= 0.544); 24-72 hpf, 86.14±8.96 (p = 0.0831). 
**, p-value<0.01). I) The effect of the three BIO-treatments applied in the 24-48, 48-72 and 24-72 hpf 
time windows is shown on Mitfa only as compared to the case of no treatment. The 24-48 and 48-72 hpf 
BIO-treatments induce an approximately equal increase of Mitfa as measured at the end of the treatment. J) 
Revised GRN model. Scale bars: 100 µm  
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Figure 5: Inactivation of Wnt signalling during melanocyte differentiation enhances melanocyte clustering in 
posterior dorsal head. Tg(hsp70l:tcf3-deltaC-GFP) embryos were heat shocked at 29 hpf, 36 hpf, 48 hpf and 
62 hpf and observed at 73 hpf (B, D, F, H) and compared to control non-heat-shocked transgenic 
Tg(hsp70l:tcf3-deltaC-GFP) (A, C, E, G). Note the enhanced clustering of melanocytes in the posterior part 
of the dorsal head in treated embryos (blue arrows) ; the normal distribution in this area in untreated 
controls is indicated by red arrows. Heat shock activation of Wnt inhibition consistently resulted in smaller 
heads and eyes. Scale bars: 100 µm.  
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 3 
Summary 
A role for Wnt signaling in melanocyte specification from neural crest is conserved across vertebrates, 
but possible ongoing roles in melanocyte differentiation have received little attention. Using a systems 
biology approach to investigate the gene regulatory network underlying stable melanocyte 
differentiation in zebrafish highlighted a requirement for a positive feedback loop involving the 
melanocyte master regulator Mitfa. Here we test the hypothesis that Wnt signaling contributes to that 
positive feedback. We show firstly that Wnt signaling remains active in differentiating melanocytes 
and secondly that enhanced Wnt signaling drives elevated transcription of mitfa. We show that 
chemical activation of the Wnt signaling pathway at early stages of melanocyte development 
enhances melanocyte specification as expected, but importantly that at later (differentiation) stages it 
results in altered melanocyte morphology, although melanisation is not obviously affected. 
Downregulation of Wnt signaling also results in altered melanocyte morphology and organisation. We 
conclude that Wnt signaling plays a role in regulating ongoing aspects of melanocyte differentiation in 
zebrafish.    
Significance 
Gene regulatory networks underlie all aspects of the development of specific cell-types. While fate 
specification mechanisms and key genes associated with differentiation are often well-studied, 
mechanisms leading to maintenance of the differentiated state are less well understood, yet they are 
crucial from a disease perspective. Positive feedback loops are predicted to be crucial to these 
maintenance mechanisms. We predicted that such a feedback loop acting on mitfa would be crucial for 
melanocyte maintenance, and provided evidence supporting this hypothesis. Here we provide 
evidence for the first time that in zebrafish ongoing Wnt signaling is likely to contribute to this 
feedback loop.  
Introduction 
Melanocytes are a key derivative of the neural crest, and the mechanisms of melanocyte development 
are of major interest from developmental and stem cell biology and applied biology perspectives, with 
clear relevance to understanding human pigmentary disease (Yamaguchi and Hearing 2014; White et 
al., 2011; Speeckaert et al., 2014; Aoude et al., 2015; Mort et al., 2015). Melanocyte specification 
from neural crest cells has been relatively well-studied, and has illuminated the underlying 
mechanisms of neurocristopathies like the Waardenburg syndromes (Dutton et al., 2001; Lee et al., 
2000; Southard-Smith et al., 1998; Elworthy et al., 2003). Numerous genes contributing to the 
differentiated melanocyte phenotype have been described, but little is known of how stable 
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 4 
melanocyte differentiation is maintained, although this is likely to be significant in understanding 
melanoma where reversion to a more progenitor-like state helps drive proliferation and invasiveness 
(White et al., 2011; Kaufmann et al., 2016). Stability of differentiation is likely to be an emergent 
property of the state of the gene regulatory network (GRN) in differentiated melanocytes.  
Studies in both mouse and zebrafish have shown that melanocyte specification depends upon the 
expression in neural crest cells of Microphthalmia-related Transcription Factor (Mitf; mitfa in 
zebrafish), which encodes a basic Helix-Loop-Helix transcription factor (Steingrimsson et al., 1994; 
Hodgkinson et al., 1993; Lister et al., 1999; Watanabe et al., 2002; Opdecamp et al., 1997). Mitf/mitfa 
functions as the master regulator of melanocyte development as it controls all aspects of melanocyte 
cell biology including melanocyte survival, proliferation, morphology and melanogenesis itself 
(Steingrimsson et al., 2004; Cheli et al., 2010; Levy et al., 2006; Lister et al., 1999). Transcriptional 
activation of Mitf/mitfa depends upon Sox10, a transcription factor of the Sry-related HMG domain 
type, shown to bind directly to the Mitf/mitfa promoter (Hou et al., 2006; Kelsh 2006; Herbarth et al., 
1998; Southard-Smith et al., 1998; Dutton et al., 2001; Elworthy et al., 2003). In addition, Wnt 
signaling, acting via Lef-1 and β-catenin mediated regulation of Mitf/mitfa transcription, is also 
required for melanocyte specification (Dorsky et al., 1998; Jin et al., 2001; Dorsky et al., 2000; 
Takeda et al., 2000; Dunn et al., 2000; Lee et al., 2004; Hari et al., 2012). Thus, the combined actions 
of early Wnt signaling and Sox10 drive expression of Mitf/Mitfa, which acts as a central node in the 
melanocyte GRN, activating numerous genes associated with all aspects of melanocyte differentiation 
(Cheli et al., 2010). Importantly, work in zebrafish has shown that a majority of neural crest cells 
express mitfa transiently, but only a subset form melanocytes (Curran et al., 2010). Thus maintenance 
of mitfa expression in a subset of neural crest cells is an important, but under-appreciated, aspect of 
melanocyte development and, indeed, likely represents a crucial part of the molecular basis for 
melanocyte fate commitment; cells in which mitfa expression is not maintained adopt alternative 
neural crest fates. 
 
As a first step in understanding how this GRN results in stable maintenance of melanocyte 
differentiation, we used a systems biology approach, taking advantage of the zebrafish model to allow 
rapid iterative cycles of mathematical modelling and biological testing of a core melanocyte GRN 
(Greenhill et al., 2011). Three cycles of this approach resulted in an expanded core network that 
incorporated a number of hypothetical components for which we also provided experimental support 
(Fig. 1A; Greenhill et al., 2011). One of these hypothetical components was a predicted Factor Y that 
enabled stabilisation of melanocyte differentiation by contributing to a positive feedback loop 
regulating mitfa expression (Greenhill et al., 2011). We showed that whilst initial expression of mitfa 
is driven by Sox10, sox10 then was gradually lost from differentiating melanocytes, being 
undetectable by in situ hybridisation or whole-mount immunofluorescence by c. 50 hours post 
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 5 
fertilisation (hpf). Importantly, we showed that continuing sox10 expression is not required for 
melanocyte differentiation and indeed, may even delay this process. In the Greenhill study we showed 
that Mitfa itself contributed to maintenance of mitfa expression, but left the identity of other possible 
components of the feedback loop unknown.  
 
The canonical Wnt pathway functions via regulation of nuclear β-catenin levels; Wnt protein binding 
to its transmembrane receptor, Frizzled, displaces glycogen synthase kinase-3β (GSK3β) from the 
destruction complex, preventing degradation of β-catenin in the cytoplasm, and resulting in elevated 
β-catenin levels in the nucleus where it functions as a transcriptional activator in co-operation with a 
co-activator, Lef-1 (Kofahl and Wolf, 2010, Barker, 2008). Canonical Wnt signaling drives fate 
specification of melanocytes via Tcf/Lef binding to mitfa regulatory elements (Dorsky et al., 1998; 
Dorsky et al., 2000; Takeda et al., 2000; Jin et al., 2001; Hari et al., 2012; Dunn et al., 2000; Lee et al., 
2004) although the relevant Frizzled receptor remains elusive (Nikaido et al., 2013). In melanocyte 
fate specification, Wnt signaling functions in conjunction with Sox10 to drive mitfa expression; in a 
sox10 mutant, mitfa expression is not detectable and melanocytes do not form (Dutton et al., 2001), 
suggesting that Wnt signaling alone is insufficient to drive mitfa expression.  
 
Here we explore two possible modes by which Wnt signaling may also contribute to melanocyte 
maintenance: 1) by ongoing action alongside Sox10, and 2) in an Mitfa-dependent manner as a 
component of Factor Y (Figure 1A). We use a transgenic reporter line to show that Wnt signaling is 
active in melanocytes throughout both specification and differentiation phases. We then use small 
molecule stimulation of Wnt signaling showing first that it activates mitfa expression and is rate-
limiting for melanocyte fate specification. We then use this approach to show that stimulating Wnt 
signaling during melanocyte differentiation affects melanocyte morphology and arrangement 
according to the timing of treatment. These shape changes correlate with upregulation of mitfa 
expression levels in melanocytes. These mitfa expression changes are independent of Mitfa activity in 
the specification and early differentiation phases, but depend upon Mitfa activity during late 
differentiation. Conversely, using a transgenic repressor of Wnt signaling, we show that inhibition of 
Wnt signaling during melanocyte differentiation stages also results in melanocyte shape changes. This 
is consistent with our proposal that Wnt signaling contributes to an Mitfa-dependent positive feedback 
loop that maintains melanocyte differentiation, in a manner consistent with our mathematical model of 
the core melanocyte GRN.  
Results 
Firstly we asked whether Wnt signaling was active in melanocytes during differentiation. We 
examined embryos carrying the Tg(top:GFP) reporter in which expression of a destabilised GFP 
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 6 
(dGFP) is driven by a promoter containing four consensus LEF1 responsive elements (Dorsky et al., 
2002; van de Wetering et al., 1997; Korinek et al., 1997; Dorsky et al., 1998). We scored a sample of 
melanocytes from these fish throughout melanocyte differentiation (30-72 hpf), using a combination 
of immunofluorescent detection of dGFP and a low dose of PTU to partially inhibit melanisation to 
increase sensitivity. We readily detected the activation of dGFP in the tectum as previously described 
(Figure 1I; Dorsky et al., 2002). We also observed, for the first time, dGFP expression in melanocytes 
throughout the time-period examined (Figure 1B-G). At early stages the majority of melanocytes 
(78.5 %) had readily detectable dGFP expression, indicating that most cells at this stage were 
responding to a Wnt signal. At later stages, a significant proportion of cells still showed detectable 
dGFP expression, although by 72 hpf the proportion of cells was substantially lower (9 %), but this is 
likely to at least partly reflect the difficulties of detection of weak fluorescence in even partially-
melanised cells.  
Having shown that Wnt signaling remains active in melanocytes throughout their differentiation, we 
then tested the hypothesis that this Wnt signaling in melanocytes might contribute to regulation of 
their differentiation. We utilised a well-characterised GSK3β inhibitor, Bromoindirubin-3'-oxime 
(subsequently referred to as BIO), that has been used to investigate the effects of increased Wnt 
signaling in many model systems, including mammalian cardiomyocyte cell culture, melanoma cells 
(B16-F0), normal human melanocyte (NHM) cells,  mouse embryonic stem cells, and zebrafish (Moro 
et al., 2012; Alexander et al., 2014; Bellei et al., 2010; Sineva and Pospelov, 2010; Kim et al., 2010; 
Bellei et al., 2008; Tseng et al., 2006). Consistent with its activation of Wnt signaling in our treated 
embryos, BIO treatment throughout a 15-40 hpf time-window activated dGFP reporter expression in 
Tg(top:GFP) fish, both in the tectum and in the melanocytes (Figure 1K-L); importantly, this BIO-
treatment did not result in gross alterations to embryonic morphology.  
Wnt signaling has been shown to drive melanocyte specification from the neural crest in both mouse 
and zebrafish (Dorsky et al., 1998; Hari et al., 2012). As a further positive control for the efficacy of 
BIO-treatment in modifying Wnt signaling in our fish, we tested the prediction that BIO treatment in 
the correct time window would increase melanocyte specification, resulting in elevated melanocyte 
numbers. We used a shorter treatment phase, focused on 15-30 hpf (Figure 2A), the time when 
melanocyte specification is thought to occur in the head and trunk. As expected, this treatment 
resulted in significantly increased melanocyte number in the head of treated embryos compared with 
controls (Figure 2B-E). Taking advantage of the developmental gradient in these embryos, we 
examined the trunk and tail region of embryos fixed at the same stage to examine whether elevated 
melanocyte numbers might be preceded by elevated mitfa expression in melanocyte progenitors 
(premigratory neural crest cells). Consistent with our current working model of the melanocyte GRN, 
BIO-treated embryos showed increased mitfa expression in premigratory neural crest cells compared 
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 7 
with mock-treated controls (Figure 2G-J). Our data suggest that the increased mitfa reflects increases 
in both the levels of mitfa expression within a cell and the number of mitfa-expressing cells (Figure 
2D,E; compare with B,C), consistent with the predicted increase in melanocyte fate specification. 
Taken together our data support the conclusion that BIO treatment in a 15-30 hpf time-window results 
in elevated melanocyte specification through increased mitfa expression after activation of Wnt 
signaling. In addition, BIO-treated embryos show a reduction in ventrally-positioned mitfa+ cells, 
suggesting a transient inhibition of melanoblast migration. 
 
Having validated BIO-treatment as an effective method for elevating Wnt signaling, we then 
addressed our hypothesis that ongoing Wnt signaling might be important for melanocyte 
differentiation and maintenance. In this study, we divided melanocyte differentiation into early and 
late phases according to sox10 expression (Figure 3A). In the early differentiation phase (24-48 hpf) 
sox10 expression in melanocytes is decreasing but still detectable by WISH and immunofluorescence, 
whereas in the late differentiation phase (48-72 hpf), sox10 is not detectable by WISH or 
immunofluorescence (Greenhill et al., 2011). We analysed the consequences of boosting Wnt 
signaling via BIO treatment throughout the entire differentiation phase (24-72 hpf) and during each of 
the early and late phases of differentiation. Firstly, we tested whether these treatments gave any effects 
in terms of melanocyte cell number, focusing on the head region. In contrast to 15-30 hpf treatment, 
no increase in melanocyte number was observed after BIO treatment from 24-48 hpf (control, mean± 
s.d = 23.9±2.01; BIO, mean±s.d = 23.1±4.03, p=0.443), suggesting that Wnt-dependent melanocyte 
fate specification is complete in the head region by 24 hpf.  
 
Next we assessed melanocyte differentiation, looking for any changes associated with BIO-treatment 
during the differentiation phases. In these BIO-treatments, we saw distinctive morphological changes 
to melanocytes, but interestingly the phenotype differed depending upon the period of BIO treatment. 
Embryos treated during the early differentiation time window and examined at 48 hpf displayed a 
dramatic increase in cell dendricity (Figure 3C,E) compared with mock-treated controls (Figure 
3B,D). To quantitate this striking phenotype, we used Image J software to estimate the roundness 
parameter, an established formula relating cell perimeter and cell area (Figure 3F).  We found BIO-
treatment resulted in a significant increase in cell dendricity compared with mock-treated controls 
(mean+s.d: control, 2.44+ 0.43; BIO, 4.25+ 1.68, p = 0.004 (unpaired, one-tailed t-test)). Importantly, 
this change in cell shape at 72 hpf was not observed in 24-72 hpf  (Figure 3G-N) or 48-72 hpf 
treatments (data not shown) suggesting that this aspect of cell differentiation was only sensitive to 
Wnt signaling for a period between 24 and 48 hpf, and that the shape changes were only transient. 
Indeed, where embryos treated in this way were examined at both 48 hpf and 72 hpf, we saw a clear 
dendricity phenotype at 48 hpf, but this had recovered by 72 hpf (data not shown). In contrast, 
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 8 
embryos treated with BIO from 24-72 hpf showed disorganised melanocytes in the dorsal head; cells 
were more dispersed, disrupting the ‘U’ or ‘O’-shaped organisation typical of control embryos (Figure 
3G-J). Treatment during the late differentiation phase alone (i.e. from 48-72 hpf) resulted in a similar 
phenotype (data not shown). A Multi-Distance Spatial Cluster Analysis using Ripley's K-Function 
(Ripley, B.D., 1977)  was performed using spatstat package in R (Baddeley & Turner 2005) to 
quantify the decrease in patterned organisation of melanocytes in the dorsal head using comparable 
pictures of DMSO and BIO treated fish (Supp. Fig.1). We found that the Ripley’s K function confirms 
the non-random organisation of melanocytes in dorsal heads of DMSO treated embryos (scale of 
analysis of r=35 pixels). Indeed, at this scale of analysis, for eight of the ten embryos the observed K 
value was smaller than the expected K value if cells were randomly spread (Supp.Fig.1, 
A,B,C,E,G,H,J). The result of the Ripley’s K analysis performed on BIO treated embryos showed 
that, at r=35, the observed K values were found within the lower confidence envelop (in the grey area) 
of the graph meaning that cells were randomly spread in 90% of the cases in nine out of ten embryos 
(Supp.Fig1K-T). Conversely, 80% of the DMSO population shows a non-random cell organisation 
and 10% of the BIO treated population shows a non-random cell organisation. A Z-test was then 
performed to compare the two populations for cellular spatial organisation using the results of this 
analysis (at r=35, comparing « random » or « not-random »); the two populations were significantly 
different for this parameter (p-value =0.00164, p <0.01).  We conclude that treating embryos with BIO 
in the early phase of differentiation led to changes in cell shape, whereas ongoing BIO-treatment 
resulted in changed melanocyte arrangement. 
 
Our working model of the melanocyte GRN predicted that mitfa transcription would be increased in 
response to activation of Wnt signaling. Using quantitative RT-qPCR, we saw a BIO-dependent 
increase in mitfa transcript levels after each of the treatment windows (Figure 4A). mitfa expression 
was increased by around five fold in embryos treated from both 24-48 hpf and 48-72 hpf whereas a 
nine-fold increase was observed in embryos treated from 24-72 hpf. Combining these data with the 
melanocyte phenotype changes observed above, we suggest that elevated mitfa expression can have 
distinct effects depending upon whether cells are in a plastic progenitor state (fate specification phase) 
or are committed to the melanocyte fate (differentiation phase). 
 
Our  model (Figure 1A) proposes two modes for Wnt action, one in conjunction with Sox10 and thus 
unlikely to be significant beyond 48 hpf when sox10 expression in melanocytes is lost (Greenhill et 
al., 2011), and one as Factor Y, where it would function as part of a positive-feedback loop with Mitfa, 
and thus would be dependent upon active Mitfa. To test whether the increase in mitfa expression 
observed in BIO-treated embryos was 1) specific for melanocytes and 2) Mitfa-dependent, we used 
whole mount in situ hybridisation and RT-qPCR to assess mitfa expression in BIO treated mitfaw2 
mutants (Figure 4B-H). The mitfa
w2 
mutant is a functional null allele, but expression of mitfa 
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 9 
transcripts can be assessed by in situ hybridisation (Johnson et al., 2010). In all cases, mitfa expression 
was restricted to cells with the morphology and distribution consistent with them being neural crest or 
melanocyte lineage cells, consistent with a cell-autonomous response. Importantly, BIO-treatment of 
mitfa
w2
 mutants in a 15-30 hpf window (i.e. during cell specification, when sox10 is relatively strongly 
expressed in the melanocyte lineage) resulted in increased mitfa expression (Figure 4H), most clearly 
seen as increased numbers of cells expressing relatively high levels of mitfa, at 30 hpf compared with 
mock-treated embryos (Figure 4B,C). A 24-48 hpf BIO-treatment, assessed at 48 hpf, showed an 
elevated level of mitfa expression in mitfa
w2 
mutants, at least in the dorsal tail (Figure 4D,E). In 
contrast, BIO-treatment in a 24-72 (data not shown) or 48-72 hpf window (Figure 4F,G), assessed at 
72 hpf, did not show elevated mitfa transcription in these mitfa
w2
 mutants (Figure 4H), suggesting that 
the Wnt-mediated effect is Mitfa-dependent. Quantitation of mitfa expression levels using RT-qPCR 
confirmed the significant increase in mitfa expression after 15-30 hpf treatment even in mitfa
w2 
mutants, and the absence of a significant response after the 24-72 and 48-72 hpf time-windows. Our 
quantitative assay did not detect the change after a 24-48 hpf time-window: although consistently 
detectable by the semi-quantitative whole-mount in situ hybridisation technique, which has the 
advantage of assessing individual cells in different spatial domains, this signal is apparently masked 
by the general signal coming from the head and trunk.  We conclude that Wnt inputs on mitfa 
expression act initially through the Sox10-dependent mechanism, but then switch to functioning 
through a Sox10-independent, Mitfa-dependent positive feedback loop. 
 
As a complement to these gain-of-function studies, we tested the effects of loss of Wnt signaling 
activity during melanocyte differentiation using a conditional activation of the dominant negative T-
cell Factor 3 (Tcf3) in transgenic zebrafish carrying Tg(hsp70l:tcf3-deltaC-GFP) (Martin and 
Kimelman, 2012). As before, we tested the functionality of our experimental system by inducing heat-
shock during the specification phase of melanocyte development, from 15 to 28 hpf, and assessing 
first activation of GFP fluorescence and expression of Wnt signaling targets such as mitfa, by RT-
qPCR. Both activation of GFP and downregulation of mitfa expression were observed after heat-shock 
(data not shown). To assess the requirement for ongoing Wnt signaling in melanocyte differentiation, 
we heat-shocked embryos at each of four timepoints, 29 hpf, 36 hpf, 48 hpf, and 62 hpf before 
assessing melanocyte phenotypes in the dorsal head at 73 hpf. Two populations of embryos could be 
distinguished by the level of activation of GFP, one where embryos showed strong GFP fluorescence 
and the second population showing weak GFP fluorescence; we note that in almost all cases 
melanocytes were abundant, indicating that survival of melanocytes was usually not affected, 
although in a subset of the fish exhibiting strong GFP, melanocyte number was visibly reduced. In the 
first population (strong inhibition of Wnt signaling) melanocyte melanisation, apparent morphology 
and patterning were all abnormal, but since the gross anatomy of the embryos was also affected, these 
melanocyte phenotypes were not quantitated. However, we noticed that a subset of melanocytes in 
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 10 
each fish was abnormally rounded, melanisation was always reduced and these cells were abnormally 
patterned (Supp. Fig. 2). In the second population (weak inhibition of Wnt signaling), melanocyte 
morphology was more normal, but their patterning was modified compared to non heat-schocked 
siblings (Figure 5). We observed enhanced clustering of melanocytes, particularly in the posterior 
region of the dorsal head (Figure 5B,D,F,H, blue arrow). Again, we used Multi-Distance Spatial 
Cluster Analysis using Ripley's K-Function (Ripley, B.D. (1977)) to quantify the change in patterned 
organisation of melanocytes in the dorsal head using comparable pictures (Supp. Fig. 3). This analysis 
showed that whereas 90% of the non-heat-shocked Tg(hsp70l:tcf3-deltaC-GFP) embryos showed 
“non-random” pattern, 70 % of the heat-shocked Tg(hsp70l:tcf3-deltaC-GFP) embryos showed loss 
of organisation (« random » cell organisation – the combination of the clustered melanocytes in the 
posterior head and the unclustered melanocytes in the anterior head are together scored by the 
algorithm as more randomly organised using this scale of analysis)(scale of analysis of r=50 pixels). A 
Z-test comparing the two populations for cellular spatial organisation using the results of this analysis 
(at r=50, comparing « random » or « not-random ») showed they were significantly different for this 
parameter (p-value = 0.00244, p <0.01). We conclude that inactivating Wnt signaling during 
melanocyte differentiation in Tg(hsp70l:tcf3-deltaC-GFP) using heat shock led to significantly 
increased clustering of melanocytes in the posterior part of the dorsal head. We note that this loss-of-
function phenotype is complementary to the gain-of-function phenotype using drug treatment, 
suggesting that Wnt signaling has a consistent impact on melanocyte differentiation in zebrafish in 
vivo.  
 
We used the mathematical modelling approach we developed before (Greenhill et al., 2011) to assess 
the effects of including Wnt signaling (Supp. Fig. 3A). We incorporated Wnt signaling in both fate 
specification and differentiation phases by assuming Wnt expression to activate β-catenin/Lef-1 
(abbreviated as T), coupled in turn with an AND gate to Sox10 during specification, and by another 
AND gate to Mitfa during commitment. For such a highly migratory cell-type, melanocyte fate 
specification (in/near the dorsal neural tube) and melanocyte differentiation (during dispersion and in 
post-migratory locations) are usually anatomically distinct and, given the complexity of Wnt 
expression patterns, thus are intuitively likely to involve distinct Wnt family members. Thus, we 
postulated two independent Wnt signals, one (WntA) acting in an early, but transient, time window 
lasting to approximately 30 hpf, and another (WntB) beginning at that latter time point and extending 
throughout differentiation. We also assumed a threshold level of T required to trigger a response from 
the AND gate between Sox10 and T (Supp. Fig.3A,B), and a threshold level of Mitfa to avoid 
accidental activation of the Mitfa feedback loop (see Greenhill et al., 2011). As in Greenhill et al. 
(2011) one of the key outcomes used to judge the appropriateness of the subsequent simulations was 
that mitfa expression initially rose, and then was maintained at a substantial level. Indeed, under 
normal conditions our revised model results in expression profiles comparable to those of the original 
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 11 
Greenhill Model C (Greenhill et al., 2011). Moreover, modelling the effects of mutating the two Wnt 
signals independently behave as expected intuitively (Supp. Fig. 3C,D). In particular, in the absence 
of the first Wnt signal, WntA, melanocyte specification fails and mitfa expression remains absent 
(Supp. Fig. 3C); likewise, in the absence of the second Wnt signal, WntB, mitfa expression peaks 
transiently before disappearing rapidly, so that maintenance of the differentiated state fails (Supp. Fig. 
3D). Currently, Wnt8 has been proposed as an inducer of neural crest in zebrafish (Lewis et al., 2004), 
but knowledge of the Wnt signals underlying melanocyte development in fish is very limited, 
although Wnt8 has been shown not to be critical (Dorsky et al., 1998; Lewis et al., 2004); a testable 
prediction of our modelling is that two distinct Wnt signals drive early melanocyte fate specification 
versus later maintenance of differentiation.  
 
We then assessed in silico the effect of increasing Wnt signaling strength in each of the specification 
and (early, late and full) differentiation phases. We did this by modifying the amount of WntA and 
WntB driving expression of T, and simulating accordingly the GRN response. We modelled the 
derepression of the Wnt signal due to the action of the BIO-treatment as a linear increase in time of 
WntA/B. As a consequence we expected the elevated expression of mitfa induced by BIO to be 
proportional to the duration of the BIO-treatment. Indeed, by choosing parameter values compatible 
with values in the literature (see Materials and Methods), the simulations show a relative increase of 
Mitfa expression in response to BIO compatible with the experimental data (Fig. I). In particular we 
show that when BIO is applied for the same amount of time (namely in the time windows 24-48hpf 
and 48-72hpf) the increase in mitfa is approximately the same. In contrast, when BIO is applied 
between 24-72 hpf, our simulations show a larger mitfa increase, roughly comparable with the 
observed linear dependency. Thus, our revised model with its more precise delineation of the roles of 
Wnt signals at different phases in melanocyte development continues to correspond well to the key 
experimental observations in vivo. 
 
Our observation that elevated Wnt signaling in the specification phase results in more cells becoming 
melanocytes is readily accounted for by the model through the threshold on T. The likelihood of an 
mitfa-expressing cell maintaining mitfa expression and thus differentiating into a melanocyte depends 
on T being above this threshold in the specification phase. In a population of cells, we expect 
stochastic variations in the levels of WntA (and hence T) will result in this condition not being 
satisfied in some cells. If BIO is applied early, T levels are enhanced, and therefore during the 
specification phase (i.e. prior to commitment) the proportion of cells proceeding successfully towards 
the melanocyte state is predicted to increase. In contrast, if BIO is only applied later, T levels during 
the earlier specification window are unaffected, so no change in the final number of melanocytes is 
predicted, in agreement with our experimental data.   
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Discussion 
 
We conclude that in addition to the established role for Wnt signaling in melanocyte specification 
from the neural crest, Wnt signaling has an ongoing influence on melanocyte differentiation at least 
until 72 hpf. By using a transgenic reporter strain we demonstrated that Wnt signaling remained 
detectable in differentiated melanocytes until 72 hpf at least. We then used BIO to assess the effects of 
increased Wnt signaling on melanocyte development in zebrafish embryos, showing that such 
treatment resulted in elevated mitfa expression in the neural crest and melanocyte lineage cells. 
Interestingly, we observed defects in melanocyte morphology with an increase in cell dendricity at 48 
hour post fertilisation (hpf) and altered cell organisation at 72 hpf. We complemented these gain-of-
function studies with a loss-of-function approach, using a conditional dominant negative transgenic 
line to inhibit Wnt signaling activity during melanocyte differentiation phases. Importantly, our data 
showed that this resulted changes in melanocyte morphology (when dnTcf3 strongly expressed), 
resulting for example in enhanced clustering of melanocytes in the posterior head.  This study 
demonstrates for the first time a function for Wnt signaling in zebrafish melanocytes, beyond the well-
known role in melanocyte fate specification, showing that it is important for multiple aspects of 
melanocyte differentiation. We note that our data indicates that the mode of Wnt signaling input 
changes from an Mitfa-independent/Sox10-dependent early role to an Mitfa-dependent/Sox10-
independent later role, suggesting that Wnt signaling at late stages becomes incorporated into the 
melanocyte maintenance (Factor Y) role postulated in our earlier work. We have revised our working 
model of the core GRN of melanocyte development in zebrafish to incorporate these new data (Figure 
4J). It is likely that Wnt signaling has a similar role in mammalian melanocytes since GSK3β 
inhibition results in upregulation of MITF expression and differentiation in normal human 
melanocytes, at least in cell culture (Bellei et al., 2008).  
 
 
Although we show here that Wnt signaling continues to influence melanocyte differentiation, our 
gain-of-function experiments do not cause  obvious effects on melanisation. However, we note that 
our modelling data (Supp. Fig. 3E,F) indicates that this may be quantitatively relatively subtle (e.g. 
for dct in curves shown), so our failure to detect such an effect in vivo may be simply due to lack of 
sensitivity in our assay. A study of normal human melanocytes in tissue culture showed that GSK3β 
inhibition stimulated melanogenesis through activation of MITF (Bellei et al., 2008). In contrast, in 
our loss-of-function experiments, those embryos showing highest levels of GFP and in which Wnt 
signaling was presumably most inhibited, showed a pronounced reduction in both melanin levels and 
defects in apparent cell morphology. Thus, it seems that Wnt signaling is important for all aspects of 
melanocyte differentiation, consistent with its effects on expression of mitfa. 
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The role for Wnt/β-catenin signaling in melanocyte specification through induction of Mitf expression 
is conserved in fish and mammals (Dorsky et al., 2000; Takeda et al., 2000). Our work showing that 
inhibition of GSK3-β using BIO stimulates melanoblast specification (mitfa expression) adds further 
support to this conclusion. Importantly, no increase in melanocyte cell number in the dorsal head was 
observed after 24-72 hpf treatments suggesting that melanocyte specification from neural crest cells 
does not extend much beyond 24 hpf. Furthermore, our time window studies showed that treatment 
from 15-30 hpf was sufficient to generate elevated numbers of head melanocytes that persist until at 
least 72 hpf, whereas treatment in a 24-48 hpf window did not. These data indicate, for the first time 
to our knowledge, that commitment to the melanocyte fate in zebrafish  (at least for melanocytes in 
the head region that arise in the embryo) has occurred by c. 30 hpf. As explained above, melanocyte 
specification reflects maintenance of mitfa expression in NCCs, so our data suggest that this process 
is limited by Wnt signaling. 
  
Our data demonstrate intriguing Wnt-dependent effects on melanocyte morphology and organisation. 
An in vitro study of normal human epidermal melanocytes demonstrated that increased and decreased 
levels of active β-catenin resulted in increased and decreased cell dendricity respectively (Kim et al., 
2010). They further showed that this resulted from activation of distinct downstream modulators, 
PKCf and PKCd, respectively (Kim et al., 2010). They showed that overexpression of PKCf resulted 
in the decrease of protein levels for Rac1 and Cdc42 and consequently a reduction of dendrite 
formation in melanocytes, while overexpression of PKCd led to increase of Rac1 and Cdc42 and an 
increase in melanocyte dendrites. We show here that elevated Wnt signaling results in increased mitfa 
expression and increased dendricity, suggesting a causal link between mitfa expression levels and cell 
shape. This idea is strongly supported by earlier studies in Xenopus embryos showing that increased 
X-mitfa expression resulted in increased melanocyte dendricity and cell dispersal (Kumasaka et al., 
2005; Kawasaki et al., 2008). Further studies will be required to test whether Wnt signaling in 
zebrafish causes increased melanocyte dendricity through a pathway of mitfa-dependent activation of 
PKCd, elevated levels of activated Rac and Cdc42, and consequent modifications of the actin 
cytoskeleton. 
 
In summary, our work defines two phases of Wnt signaling involvement in zebrafish melanocyte 
development in vivo, both of which are likely conserved in mammals. Recent analysis showed that the 
two transcription factors Tfap2a and Tfap2e are required for early melanocyte differentiation, through 
both maintenance of kit expression and another mechanism still to be defined (Van Otterloo et al., 
2010). It will be of interest to assess whether these roles for Tfap2 factors extends to ongoing 
maintenance of the differentiated state and, if so, the extent to which Wnt signaling and Tfap2/Kit 
function are integrated in this system. 
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Figure legends 
Figure 1.  
 Ongoing Wnt signaling is detectable in differentiating melanocytes. 
 (A) Diagram of working model for melanocyte core GRN (modified from Greenhill et al., 2011). 
Note two inputs from Wnt signaling on mitfa expression, one well-established role acting alongside 
Sox10 driving melanocyte fate specification, and hypothetical role explored here as part of a positive 
feedback loop also involving Mitfa itself. B-G) Wnt signaling in differentiating melanocytes was 
assessed by scoring samples of melanocytes for detection of dGFP by immunofluorescence in 
Tg(top:GFP) transgenic embryos from 30-72 hpf. GFP-positive melanocytes (arrows) are shown by 
immunofluorescence (B,D,F) and DIC (C,E,G) to show melanin pigment. At each stage, 30 
melanocytes in each of 15 embryos were assessed for GFP expression, in the dorsal head and 
throughout the dorsal and lateral trunk; numbers show the percentage of melanocytes expressing GFP 
(mean ± s.d) at corresponding stages (n = 450 per stage). H) Schematic showing timing of BIO 
treatment used. I-L) BIO-treatment enhances activity of Tg(top:GFP) reporter. BIO-treatment from 15 
hpf to 40 hpf dramatically enhances dGFP expression (red arrows) in the tectum of treated (K) 
compared with mock-treated controls (I) and also increases dGFP signal in melanocytes of 
Tg(top:GFP) embryos (BIO-treated (L) compared with mock-treated control (J)). All images, lateral 
views using confocal microscopy.  EM, embryo medium; e: eye; T: tectum. Scale bars: B-G) 10 µm; 
I-L) 100 µm.  
 
Figure 2. 
Elevated Wnt signaling in melanocyte specification time window increased numbers of 
melanocytes. A) Schematic showing timing of BIO treatment or control mock-treatment (DMSO 
alone) used. B-E) Lateral views of the trunk of live 30 hpf zebrafish embryos showing melanocytes 
(red arrows); note increased number in both anterior (D) and posterior trunk (E) of embryos treated 
with 5 µM BIO compared with control DMSO treated embryos (B,C respectively). F) Quantitation of 
increased melanocyte number in heads of BIO-treated embryos (mean ± s.d.; control, 13 ± 2.1; BIO, 
32 ± 5.3, p<10
-6
) (n= 20; *** indicates significant difference between treated and mock-treated; 
unpaired, one-tailed t-test). G-J). Lateral views of posterior trunk (G,I) and close-up of anterior tail 
(H,J) of 30 hpf zebrafish embryo in situ hybridisations to show mitfa expression in embryos treated 
with BIO (I,J) or DMSO control (G,H). In the DMSO control embryos (G,H) discontinuous mitfa 
expression is observed in the dorsal region (blue arrows show discontinuities of the signal), whereas 
in the BIO treated embryos (I,J) mitfa expression is continuous throughout the dorsal region (red 
arrows). Images show representative phenotypes (n=20 per treatment). Scale bar: 100 µm.  
 
Figure 3: Elevated Wnt signaling in melanocyte differentiation time window alters melanocyte 
morphology. A) Schematic of melanocyte differentiation BIO-treatment time-windows. B-E) 
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Activation of Wnt signaling in early differentiation period (24-48 hpf) increases melanocyte 
dendricity and dispersion. Lateral view at 48 hpf of head of live embryos treated with control DMSO 
(B) or BIO (C) from 24-48 hpf. Panels D and E show enlargements of head melanocytes from 
embryos in B and C respectively. F) Quantitation of dendricity: the cell roundness parameter was 
calculated for each melanocyte as R = P2 ⁄ 4∏A, where A is the cell area and P the cell perimeter, 20 
cells were investigated (n=20) in 10 different embryos for each condition. A score of R=1.0 represents 
a perfectly round melanocyte; increased R values represent increased dendricity. Control, R=2.44 ± 
0.43, BIO R= 4.25 ± 1.68, p = 0.004, t-test result, p-value<0.01 (**). G-J) Elevated Wnt signaling 
throughout full differentiation or during late differentiation window only affects melanocyte 
organisation. Red line in G indicates the dorsal head melanophores which usually approximate an O- 
or U-shaped pattern, although often with extra branches as in this specific example. Dorsolateral view 
at 72 hpf of heads of live embryos treated with control DMSO (G,I,K,M) or BIO (H,J,L,N) from 24-
72 hpf shown. Note that embryos treated in only Late Differentiation window (48-72 hpf) show 
equivalent phenotype (data not shown). Embryos shown are representative of samples examined 
(n=160 zebrafish embryos for each treatment). Scale bars: 100 µm (B,D,G,I). 
 
Figure 4: Positive feedback between Wnt signaling and Mitfa during late differentiation phase 
of melanocyte development. A) Quantitation of mitfa expression by RT-qPCR showing significantly 
increased levels in BIO-treated embryos compared with untreated controls; data are expressed as 
percentage of mock-treated controls (control mitfa level = 100 % transcripts (red line on graph)). 
Gene expression was investigated in 10 samples consisting of the trunk and tail of 50 embryos for 
each condition and in triplicate, after normalisation to the stable expression of a reference house-
keeping gene, gapdh. All treatments caused significant increase of mitfa expression (t-test, two- tailed: 
24-48 hpf, 535±7.1 (p= 0.00087); 48-72 hpf, 496±9.8(p= 0.0085); 24-72 hpf, 872±32.1 (p = 
0.000092). ***, p-value<0.001). B-G) Activating Wnt signaling after 48 hpf does not affect mitfa 
expression in mitfa
w2
 mutant embryos during melanocyte differentiation. Lateral views of trunk 
showing in situ hybridisation for mitfa expression in mitfa mutant fish. mitfa mutant embryos treated 
with BIO in the melanocyte specification phase (15-30 hpf) (C) showed increased mitfa expression 
(purple) compared to DMSO-treated embryos (B). Similarly, mitfa mutant embryos treated with BIO 
in the melanocyte early differentiation phase (24-48 hpf) (E) showed increased mitfa expression in tail 
dorsal stripe melanocytes compared to DMSO-treated embryos (D). In contrast, mitfa mutant embryos 
treated with BIO throughout the late melanocyte differentiation phase (48-72 hpf) (G) did not show 
increased mitfa expression compared to DMSO-treated embryos (F) at 72 hpf. 40 zebrafish embryos 
were investigated for each condition; BIO-treated and matched control embryos were processed for in 
situ hybridisation in parallel and under identical conditions. H) Quantitation of mitfa expression by 
RT-qPCR showing significantly increased levels in BIO-treated embryos at 30 hpf compared with 
untreated controls but not at 48 hpf nor at 72 hpf; data are expressed as percentage of mock-treated 
Page 52 of 65Pigment Cell & Melanoma Research Proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 16 
controls (control mitfa level = 100 % transcripts (red line on graph)). Gene expression was 
investigated in triplicate, after normalisation to the stable expression of a reference house-keeping 
gene, gapdh. Only 15-30 hpf treatment caused significant increase of mitfa expression (t-test, two- 
tailed: 15-30 hpf, 160.39±7.27 (p=0.0020); 24-48 hpf, 108.15±7.9 (p= 0.0675); 24-72 hpf, 104.6±8.36 
(p= 0.544); 24-72 hpf, 86.14±8.96 (p = 0.0831). **, p-value<0.01). I) The effect of the three BIO-
treatments applied in the 24-48, 48-72 and 24-72 hpf time windows is shown on Mitfa only as 
compared to the case of no treatment. The 24-48 and 48-72 hpf BIO-treatments induce an 
approximately equal increase of Mitfa as measured at the end of the treatment. J) Revised GRN 
model. Scale bars: 100 µm  
 
Figure 5: Inactivation of Wnt signalling during melanocyte differentiation enhances melanocyte 
clustering in posterior dorsal head. Tg(hsp70l:tcf3-deltaC-GFP) embryos were heat shocked at 29 
hpf, 36 hpf, 48 hpf and 62 hpf and observed at 73 hpf (B, D, F, H) and compared to control non-heat-
shocked transgenic Tg(hsp70l:tcf3-deltaC-GFP) (A, C, E, G). Note the enhanced clustering of 
melanocytes in the posterior part of the dorsal head in treated embryos (blue arrows) ; the normal 
distribution in this area in untreated controls is indicated by red arrows. Heat shock activation of Wnt 
inhibition consistently resultsed in smaller heads and eyes. Scale bars: 100 µm. 
 
Supplemental data 
Supplementary Figure 1: Ripley’s K function analysis shows significant decrease in melanocyte 
organisation in BIO-treated embryos compared to DMSO-treated embryos at 72 hpf. 
Ripley’s K function analysis was performed on 10 DMSO treated embryos (A-J) and 10 BIO 
treated embryos (K-S). The expected values for K if the cells are randomly spread are 
represented by the red dotted line on the graph; the grey area corresponds to area between the 
lower and higher confidence envelope/interval for values of K. Based on inspection of control 
embryos, and noting that the dorsal head melanocytes are clearly patterned, we set the scale 
of analysis to r=35 pixels (blue arrows and blue lines). Significant clustering then 
corresponds to the white zone underneath the grey area whereas significant dispersion 
corresponds to the white area above the grey area. As expected, 8 out of 10 DMSO-treated 
control embryos are scored as showing a clustered pattern (below the grey area; embryos A-
E,G,H,J).  In contrast, Ripley’s K function analysis performed on BIO treated embryos 
showed that the observed K values were found within the lower confidence envelope (in the 
grey area) of the graph in nine out of ten embryos (embryos K-S), so that cells appeared 
randomly dispersed in 90% of the cases.  
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Supplementary Figure 2: Strong expression of a dntcf3 transgene results in poor melanocyte 
differentiation. Transgenic Tg(hsp70l:tcf3-deltaC-GFP) embryos that were heat shocked at each of 
29, 36, 48 and 62 hpf and which showed strong GFP expression (A,C,E) demonstrate a strong 
melanocyte phenotype including reduced melanisation and more rounded shape (red arrowheads) at 
73 hpf compared to non-heat-shocked control transgenic embryos (B,D,F). Scale bars: 100 µm. 
 
Supplemental Figure 3: Ripley’s K function analysis shows significant decrease in melanocyte 
organisation when Wnt signalling is impaired in dntcf3 transgenic embryos at 72 hpf. 
Ripley’s K function analysis was performed on 10 control non-heat-shocked transgenic 
Tg(hsp70l:tcf3-deltaC-GFP) embryos (A-J) and 10 heat-shocked transgenic Tg(hsp70l:tcf3-deltaC-
GFP) embryos (K-T). The expected values for K if the cells are randomly spread are represented by 
the red dotted line on the graph; the grey area corresponds to area between the lower and the higher 
confidence envelope/interval for values of K. Based on inspection of control embryos, and noting that 
the dorsal head melanocytes are clearly patterned, we set the scale of analysis to r=50 pixels (blue 
arrows and blue lines). Significant clustering then corresponds to the white zone underneath the grey 
area whereas significant dispersion corresponds to the white area above the grey area. As expected, 
eight out of ten control embryos are scored as showing a clustered pattern (below the grey area; 
embryos A-E,G,H,J).  In contrast, Ripley’s K function analysis performed on heat-shocked embryos 
showed that the observed K values were found within the lower confidence envelope (in the grey 
area) of the graph in seven out of ten embryos (embryos K-S), so that cells showed ‘lower 
organisation’ in 70% of the cases. 
 
Supplementary Figure 4:  
A) Core GRN for melanocyte differentiation activated by Wnt signaling.  Extension of Gene 
Regulatory Network as from Greenhill et al., (2011) with inclusion of β-catenin/Lef-1 (indicated in 
the diagram as T) mediated Wnt activation.  The complex β-catenin/Lef-1 is assumed to work in 
conjunction with Sox10 and Mitfa through AND gates. Two components of Wnt signaling (WntA and 
WntB) are also assumed to participate selectively in fate specification and commitment respectively. 
B) Schematic of WntA and WntB signaling. 
We show the time profile of the Wnt components, WntA and WntB, as used in this model. The first 
component is active between times 15-30 hpf and activates production of nuclear T (plotted) above 
the threshold value while the second component is active for times beyond 30 hpf and has a lower 
affinity not enough to induce a production of T above threshold. Note that although modelled here as 
differences in affinity for their receptors, exactly equivalent outcomes would result if their affinities 
were identical, but WntA and WntB expression levels differed. 
C-D) Selective failure of specification and commitment. 
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We plot the response of the GRN to either Wnt component acting alone. When only WntA is active 
(C) we have specification but only transient differentiation (Mitfa increases initially, but then decays 
to zero) while when only WntB is active (D) Mitfa production is never observed. The traces of Sox10 
(red curve), Z (orange), T (blue), Dct (dark green), Tyrp1 (brown), A (black) and Mitfa (light green) 
are plotted as a function of time (hours after fertilisation, hpf). 
E-F) Simulation of the core GRN according to the mathematical model (see Methods). 
The traces of Sox10 (red curve), Z (orange), T (blue), Dct (dark green), Tyrp1 (brown), A (black) and 
Mitfa (light green) are plotted as a function of time (hrs). Solid lines correspond to time-courses 
without BIO treatment while circles correspond to those with BIO treatment.  E) BIO treatment is 
applied between 24 and 48 hpf, Mitfa (light green circles) is amplified 2-fold at 48 hrs as compared to 
the evolution without BIO treatment (light green line) at the same time. F) BIO treatment is applied 
between 24 and 72 hpf, Mitfa (light green circles) is amplified 3-fold at 72 hrs as compared to the 
evolution without BIO treatment (light green line) at the same time.  
 
Methods 
Fish Husbandry 
Wild type (AB) and transgenic Tg(-7.2sox10:EGFP) (Carney et al., 2006) and Tg(top:GFP)) (Dorsky 
et al., 2002) and mutant mitfaw2 (Lister et al., 1999) zebrafish, Danio rerio, were kept in the aquarium 
at the University of Bath. Tg(hsp70l:tcf3-deltaC-GFP) (=w26Tg) fish (Martin and Kimelman, 2012) 
were kept in the facilities of the Department of Developmental and  Cell Biology, School of 
Biological Sciences at the University of California, Irvine. Natural crosses were set up overnight and 
embryos collected in the morning. Embryos were placed in embryo medium and grown at 28.5 °C. 
They were staged according to Kimmel et al., (1995). Where embryos were to be manipulated 
between laying and hatching we used Watchmakers’ No5 forceps to dechorionate the embryos. 
Embryos older than 15 hpf which were to be manipulated in any way were anaesthetised with Tricaine 
(Ethyl 3-aminobenzoate methanesulphonate, 4 g/L stock, final concentration approximately 0.2 % 
v/v). Where appropriate, melanisation was inhibited using PTU (1-phenyl-2-thiourea) from 24 hpf at a 
final concentration of 0.0015 % in embryo medium. All experiments complied with institutional and 
national animal welfare laws, guidelines and policies. Procedures involving fish older than 5 dpf were 
undertaken under licence from the UK Home Office.  
 
 
BIO (2'Z,3'E)-6-Bromoindirubin-3'-oxime) treatment 
BIO (2'Z,3'E)-6-Bromoindirubin-3'-oxime):  GSK3β inhibitor (Calbiochem) was stored as a 10 mM 
stock solution in DMSO. Ten wild type or mitfaw2 mutant embryos were placed in triplicate into 6-cm 
petri dishes containing 8 ml embryo medium. All embryos were dechorionated before 10 mM BIO 
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(361550 GSK-3 Inhibitor IX, Calbiochem) in DMSO was added to each experimental dish to a final 
concentration of 5 µM; an equivalent volume of DMSO was added to the control dishes. Embryos 
were incubated under standard conditions from 15-30, 24-48, 48-72 or 24-72 hpf.   
 
Heat-shock experiment 
Tg(hsp70l:tcf3-deltaC-GFP) transgenic embryos (Martin and Kimelman, 2012) were heat shocked at 
39°C  for 12 minutes at four timepoints (29 hpf, 36 hpf, 48 hpf and 60 hpf) during melanocyte 
differentiation;  after heat-shock, embryos were assessed for GFP expression  and left to develop at 
28.8°C in incubator. Embryos were assessed for melanocyte differentiation defects at 73 hpf.  
Whole mount in situ hybridisation 
RNA in situ hybridisation was performed according to Thisse and Thisse, (2008) except probes were 
not hydrolysed and embryos were incubated at 68 °C in hybridization steps. Probes used were sox10 
(Dutton et al., 2001), mitfa (Lister et al., 1999), xdh (Parichy et al., 2000). (Plasmid and probe 
generated by T. Chipperfield and C. Nelson). 
 
RNA extraction and cDNA synthesis   
RNA was extracted from samples consisting of 50 whole embryos of each condition using TRI 
REAGENT (Sigma-Aldrich, T9424)  according to manufacturer’s instructions and purified and 
precipitated by phenol/chloroform/isoamylalcohol (25:24:1). The RNA pellet was washed in 1ml 75% 
ETOH by inverting the tube gently. A 1 µl sample was assessed for purity, integrity by gel 
electrophoresis, and concentration was measured spectrophotometrically. When required, samples 
were stored at -80°C for not more than a month. For experiment using WT embryos, first strand 
cDNA was synthesised using the Invitrogen First strand cDNA synthesis kit with Superscript III and 
oligodT (Promega), 0.5 µl random hexamers (250ng/µl) (Promega), 5 µl dNTPs (2mM) (Promega), 
7.5 µl RNA (1 µg of total RNA) were first mixed and incubated for 5 mins at 65
o
C and then at least 1 
min at 4oC. Second, 4 µl of 5X first strand buffer (Invitrogen), 1 µl of 5mM DTT, 1 µl RNAse out 
(Invitrogen) and 1 µl superscript III (Invitrogen) RTase/Mµl were added to the previous mix and left 5 
minutes at 25 oC, 60 oC minutes at 50 oC, 15 minutes at 70 oC. Finally, samples were diluted 1:5 and 
concentrations were measured spectrophotometrically. For experiments using mitfa
w2
 mutant 
embryos, RNA extraction was performed by Direct-zol™ RNA MiniPrep (Zymo Research) and the 
iScript™ Advanced cDNA Synthesis Kit (Bio-Rad) was used for reverse transcription of 1 µg RNA in 
20 µl reaction according to manufacturer’s protocol. 
 
Real-time quantitative PCR   
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.Real time quantitative PCR was performed in triplicate using SYBR Green I PCR Master Mix 
(Roche) for WT embryos and a Lightcycler II machine (Roche) was used according to the 
manufacturer’s instructions. For mitfaw2 mutant embryos, the Fast SYBR® Green Master Mix 
(ThermoFisher) was used and samples were run in triplicate using the StepOne™ System 
(ThermoFisher) according to manufacturer’s instructions. Standard curves for both gapdh and mitfa 
primers demonstrated nearly 100% efficiency (98.7% and 98.5%, correspondently). Primers were 
designed spanning an intron using Primer3 Plus software (http://www.bioinformatics.nl/cgibin/ 
primer3plus/primer3plus.cgi.). The following primers were used:  
gapdh: forward 5'ACCAACTGCCTGGCTCCT3',  
            reverse 5'TACTTTGCCTACAGCCTTGG3';  
mitfa: forward 5'CTGGACCATGTGGCAAGTTT3',  
           reverse 5'GAGGTTGTGGTTGTCCTTCT3'  
Gene expression was normalized against zebrafish gapdh expression in wild-type embryos. RT-qPCR 
data were analysed using the (∆∆Ct) method (Livak et al., 1998). Student’s t-test was performed using 
GraphPadPrism 5.0. In all tests, difference was considered significant if p<0.001. 
 
Immunofluorescence  
Embryos for immunofluorescent detection were processed following the protocol proposed by (Ungos 
et al., 2003). Embryos were fixed in 4 % Paraformaldehyde in PBS (Phosphate buffered saline, 
Oxoid) overnight at 4 °C. They were washed three times for 5 minutes in PBTriton (0.1 % Triton X-
100 Sigma-Aldrich in PBS) and three times for one hour in MilliQ water. Embryos were incubated in 
block solution (1 % DMSO, 5 % Goat/Sheep serum diluted in PBTriton) for 2 to 3 hours. They were 
then incubated at room temperature overnight in polyclonal mouse serum primary antibody 
(Polyclonal IgG Rabbit Anti-GFP Primary Antibody, Invitrogen, A11122) diluted 1:500 in block 
solution.  Embryos were washed in PBTriton once briefly and three times for one hour. They were 
incubated overnight 4 °C in Alexa Fluor 488 fluorescent anti-rabbit secondary antibody (Polyclonal 
IgG Alexa Fluor 488 donkey anti-rabbit, Invitrogen, A21206) diluted 1:200 in block solution. 
Embryos were then washed once briefly and three times for 30 minutes in PBTriton. They were stored 
in 50 % glycerol for imaging and storage.  
 
Microscopy 
Fish were mounted between bridged coverslips in methylcellulose for live embryos, anesthetized with 
0.003 % MS222 (Sigma), and in 80 % glycerol for fixed embryos. Embryos were photographed using 
a Spot digital camera (supplier) mounted on an Eclipse E800 microscope (Nikon) or Axioplan 2 
microscope (Zeiss) with DIC optics using a Spot digital camera mounted on a MZ12 microscope 
(Leica) with epi-illumination or Nikon sight DS-U1 camera (Nikon). To minimise the effects of the 
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developmental gradient along the body axis, melanocyte counts were performed on the head only, 
from the anteriormost region (forebrain) to the rear of the otic vesicle (posterior hindbrain); 
melanocytes were counted only in the region dorsal to the CNS (i.e the developing dorsal stripe). 
 
 
Dendricity measurement 
Dendricity was calculated as R (R = P2 ⁄4pA, where A is the cell area and P the cell perimeter), cell 
perimeter and area was measured using ImageJ software from images of cells taken using Eclipse 
E800 microscope (Nikon). 
Ripley’s K function analysis 
To quantify and compare melanocyte organisation in DMSO treated embryos and BIO treated 
embryos the Multi-Distance Spatial Cluster Analysis, based on Ripley's K-Function, was 
performed using R statistical software (using packages "spatstat" and "dplyr" (R Core Team (2012)).  
Melanocyte positions were determined on the dorsal head of ten treated 72 hpf embryos for each 
conditions (DMSO and BIO treated) using comparable pictures. x and y coordinates for each 
melanocyte’s position was determined using ImageJ. This data was then used to perform the 
Ripley’s K function analysis which allows testing for random partition of the cells.  
A Z-test allowed comparison of the two populations for cellular spatial organisation using the 
results of this analysis; the result was considered significant if p<0.01. 
 
Statistics 
Data were analysed by Prism 3.0 software GraphPadPrism 5.0 using unpaired t-test, α=0.05%, n=20 
and fd= (x-2), with x = number of embryo tested. 
 
Mathematical Modelling 
Following the scheme of Supp. Fig. 3A and indicating the molecular species with their initials (except 
Tyrp1, indicated with  yT )  we describe the behaviour of the GRN by the following set of ordinary 
differential equations: 
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All equations have been derived from the network scheme in Supp. Fig. 3A   by applying the rules 
explained in Greenhill et al. (2011).  In addition, here we consider β-catenin/Lef-1 (T) acting in 
conjunction with either Sox10 (S) or Mitfa (M) via an AND gate in order to activate the production of 
Mitfa itself. This means that Mitfa production is activated only when either of the two AND gates 
involving T (one with Sox10 and the other with Mitfa) is active. The AND gate with Sox10 is 
activated only when the concentration of T is larger than a given thresholdT .  A second threshold M
on the concentration of Mitfa is operative also on the self-activating loop of Mitfa. 
 
The core of the network corresponds to what has already been modelled in Greenhill et al. (2011) with 
the addition of Wnt signaling. Wnt is assumed to have two components WntA (WA in the equations 
above) and WntB (WB) both activating transcription factor β-catenin/Lef-1 (indicated as T in the 
equations). The binding and unbinding dynamics of Wnt is assumed to be fast as compared to the 
other network reactions and therefore Wnt is assumed to be equilibrated at any time. The first 
component WntA is present only for a transient time between 15 and 30 hpf, while the second 
component WntB starts at 30 hpf and remains active throughout the whole differentiation process (see 
Supp. Fig. 3B).  When these two components act together they guarantee specification and 
commitment of the melanocytes lineage. If only WntA is present then we have specification but no 
commitment (see Supp. Fig. 3C) while if only WntB is present no specification is observed (Supp. 
Fig. 3D). Notice that this mechanism relies on the presence of a threshold on the activation of the 
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AND gate between Sox10 and T which prevents the production of Mitfa and therefore the activation 
of Mitfa’s feedback loop. In order to simulate the BIO-treatment we added a correction GBIO to the WA 
and WB components, which amounts to a time-linear increase in Wnt when the BIO-treatment is 
applied between t
S
BIO and t
E
BIO (times of start and end of the treatment respectively) and is one when 
there is no BIO-treatment.  Parameter values for the model are:  











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⋅=Γ
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=
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
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


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=
=
=
=
=
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








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=
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
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=
=
=
=
=
=
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=
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=
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13
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h)(nM 8.1
h)(nM 5.4
h)(nM 0.5
nM 75.0
nM, 01.0
nM 25.0
nM 33.0
,
nM 2.1
nM 5.6
nM 0.1
nM 8.1
nM 0.1
nM 045.0
nM 8.7
  ,
nM 5.0
,nM 5.0
nM 175.0
nM 1.0
nM 22.0
nM 0.2
nM 32.1
nM 43.1
nM 92.1
  ,
h 1.0
h 6.0
h 03.0
h 6.0
h 05.0
h 3.0
h 2.0
    ,
nM/h 3.0
nM/h 1.3
nM/h 3.0
nM/h 3.1
nM/h 35.0
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T
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Z
D
Ty
H
T
M
S
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These values are chosen in accordance with measured values from the literature (Jin & Liao, 1999, 
Schwanhausser et al., 2011 and Eden et al., 2011 for Sox10, Jao et al., 2013 for Mitfa) and within 
similar ranges as in Greenhill et al. (2011) for those unknown.  We have assumed the same affinity for 
the two Wnt components and larger concentration for WA but the opposite assumption (different 
affinity and same concentration) would lead to the same results.  A slower decay rate for Mitfa than 
the one used in Greenhill et al., 2011 produced a better quantitative agreement with BIO-treatment 
results. 
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